<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="5e422aae-977e-4abd-ad03-8852702d17b1"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use GENOTROPIN safely and effectively. See full prescribing information for GENOTROPIN<br/>
      <br/>GENOTROPIN<sup>Â®</sup> (somatropin) for injection, for subcutaneous use <br/>Initial U.S. Approval: 1987</title>
   <effectiveTime value="20250214"/>
   <setId root="ffebf88b-d257-4542-9808-74d9b7167765"/>
   <versionNumber value="34"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="134489525" root="1.3.6.1.4.1.519.1"/>
            <name>Pfizer Laboratories Div Pfizer Inc</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="354433591" root="1.3.6.1.4.1.519.1"/>
                        <name>Pfizer Health AB</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2626" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2646" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2649" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2650" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2651" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2652" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2653" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2654" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2655" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2656" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2657" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2658" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2626" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2646" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2649" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2650" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2651" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2652" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2653" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2654" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2655" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2656" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2657" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0013-2658" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="512313be-8bc1-4a19-9156-eb01d4cd0cf7"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20240823"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2626" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2626-81" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="5"/>
                                    <denominator unit="mL" value="1"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="1.14"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <quantity>
                                    <numerator unit="mg" value="45"/>
                                    <denominator unit="mL" value="1.14"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2646" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2646-81" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="12"/>
                                    <denominator unit="mL" value="1"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="1.13"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <quantity>
                                    <numerator unit="mg" value="32"/>
                                    <denominator unit="mL" value="1.13"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2649" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2649-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="0.2"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2650" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2650-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="0.4"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2651" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2651-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="0.6"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2652" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2652-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="0.8"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2653" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2653-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="1"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2654" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2654-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="1.2"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2655" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2655-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="1.4"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2656" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2656-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="1.6"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2657" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2657-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="1.8"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0013-2658" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GENOTROPIN</name>
                        <formCode code="C47916" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="KIT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>somatropin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asContent>
                           <quantity>
                              <numerator unit="1" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="7"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0013-2658-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19951220"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>somatropin</name>
                              <formCode code="C42957" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>somatropin</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="ACTIB">
                                 <quantity>
                                    <numerator unit="mg" value="2"/>
                                    <denominator unit="mL" value="0.25"/>
                                 </quantity>
                                 <ingredientSubstance>
                                    <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SOMATROPIN</name>
                                    <activeMoiety>
                                       <activeMoiety>
                                          <code code="NQX9KB6PCL" codeSystem="2.16.840.1.113883.4.9"/>
                                          <name>SOMATROPIN</name>
                                       </activeMoiety>
                                    </activeMoiety>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GLYCINE</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                        <part>
                           <quantity>
                              <numerator unit="1" value="0.25"/>
                              <denominator value="1"/>
                           </quantity>
                           <partProduct>
                              <name>water</name>
                              <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                              <asEntityWithGeneric>
                                 <genericMedicine>
                                    <name>Water</name>
                                 </genericMedicine>
                              </asEntityWithGeneric>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>WATER</name>
                                 </ingredientSubstance>
                              </ingredient>
                              <ingredient classCode="IACT">
                                 <ingredientSubstance>
                                    <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>MANNITOL</name>
                                 </ingredientSubstance>
                              </ingredient>
                           </partProduct>
                           <subjectOf>
                              <approval>
                                 <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                                 <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                                 <author>
                                    <territorialAuthority>
                                       <territory>
                                          <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                       </territory>
                                    </territorialAuthority>
                                 </author>
                              </approval>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19951220"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <consumedIn>
                              <substanceAdministration>
                                 <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                              </substanceAdministration>
                           </consumedIn>
                        </part>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020280" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19951220"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="S1">
               <id root="431b6146-e583-4081-8d5b-2f755d178c98"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1	INDICATIONS AND USAGE </title>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>GENOTROPIN is a recombinant human growth hormone indicated for:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Pediatric:</content>
                              </content> Treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi syndrome, Small for Gestational Age, Turner syndrome, and Idiopathic Short Stature (<linkHtml href="#S1.1">1.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Adult:</content>
                              </content> Treatment of adults with either adult onset or childhood onset GHD (<linkHtml href="#S1.2">1.2</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S1.1">
                     <id root="d19c3872-a039-43ec-ba89-0de757792909"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>1.1	Pediatric Patients</title>
                     <text>
                        <paragraph>GENOTROPIN is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone.</paragraph>
                        <paragraph>GENOTROPIN is indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS). The diagnosis of PWS should be confirmed by appropriate genetic testing<content styleCode="italics"> [see </content>
                           <content styleCode="italics">
                              <linkHtml href="#S4">Contraindications (4)</linkHtml>
                           </content>
                           <content styleCode="italics">]</content>.</paragraph>
                        <paragraph>GENOTROPIN is indicated for the treatment of growth failure in pediatric patients born small for gestational age (SGA) who fail to manifest catch-up growth by age 2 years.</paragraph>
                        <paragraph>GENOTROPIN is indicated for the treatment of growth failure associated with Turner syndrome.</paragraph>
                        <paragraph>GENOTROPIN is indicated for the treatment of idiopathic short stature (ISS), also called non-growth hormone-deficient short stature, defined by height standard deviation score (SDS) â¤-2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, in pediatric patients whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature that should be observed or treated by other means.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S1.2">
                     <id root="99d68bc5-27bb-440f-a4b0-368ee55460b2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>1.2	Adult Patients</title>
                     <text>
                        <paragraph>GENOTROPIN is indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency who meet either of the following two criteria:</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_4183eb73-de78-4435-987a-eea1ee51143d">
                           <id root="53a69eca-f301-4e5d-ab75-13b44873a41c"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Adult Onset (AO):</content> Patients who have growth hormone deficiency, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma; or</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_c456b210-608f-446c-a321-40686bea657d">
                           <id root="b2f018a4-c3e5-460a-b108-ecd87a1df6ba"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Childhood Onset (CO)</content>: Patients who were growth hormone deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes.</paragraph>
                              <paragraph>Patients who were treated with somatropin for growth hormone deficiency in childhood and whose epiphyses are closed should be reevaluated before continuation of somatropin therapy at the reduced dose level recommended for growth hormone deficient adults. According to current standards, confirmation of the diagnosis of adult growth hormone deficiency in <content styleCode="underline">both</content> groups involves an appropriate growth hormone provocative test with two exceptions: (1) patients with multiple other pituitary hormone deficiencies due to organic disease; and (2) patients with congenital/genetic growth hormone deficiency.</paragraph>
                           </text>
                           <effectiveTime value="20240823"/>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S2">
               <id root="d16a98f5-5e3b-46ef-83d4-c618b7b67a4c"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2	DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>The weekly dose should be divided into 6 or 7 <content styleCode="bold">subcutaneous </content>injections. <content styleCode="bold">GENOTROPIN must not be injected intravenously.</content>
                  </paragraph>
                  <paragraph>Therapy with GENOTROPIN should be supervised by a physician who is experienced in the diagnosis and management of pediatric patients with growth failure associated with growth hormone deficiency (GHD), Prader-Willi syndrome (PWS), Turner syndrome (TS), those who were born small for gestational age (SGA) or Idiopathic Short Stature (ISS), and adult patients with either childhood onset or adult onset GHD.</paragraph>
               </text>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>GENOTROPIN should be administered subcutaneously (<linkHtml href="#S2">2</linkHtml>)</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Pediatric GHD:</content>
                              </content> 0.16 to 0.24 mg/kg/week (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Prader-Willi Syndrome:</content>
                              </content> 0.24 mg/kg/week (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Small for Gestational Age:</content>
                              </content> Up to 0.48 mg/kg/week (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Turner Syndrome:</content>
                              </content> 0.33 mg/kg/week (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Idiopathic Short Stature:</content>
                              </content> up to 0.47 mg/kg/week (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="bold">
                                 <content styleCode="italics">Adult GHD:</content>
                              </content> Either a non-weight based or a weight based dosing regimen may be followed, with doses adjusted based on treatment response and IGF-I concentrations (<linkHtml href="#S2.2">2.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Non-weight based dosing:</content> A starting dose of approximately 0.2 mg/day (range, 0.15â0.30 mg/day) may be used without consideration of body weight, and increased gradually every 1â2 months by increments of approximately 0.1â0.2 mg/day. (<linkHtml href="#S2.2">2.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Weight based dosing:</content> The recommended initial dose is not more than 0.04 mg/kg/week; the dose may be increased as tolerated to not more than 0.08 mg/kg/week at 4â8 week intervals. (<linkHtml href="#S2.2">2.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>GENOTROPIN cartridges are color-coded to correspond to a specific GENOTROPIN PEN delivery device (<linkHtml href="#S2.3">2.3</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Injection sites should always be rotated to avoid lipoatrophy (<linkHtml href="#S2.3">2.3</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S2.1">
                     <id root="3ab2c98d-14ea-4292-89e7-a6349ce098e8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1	Dosing of Pediatric Patients</title>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_93c06f12-3b0e-4562-8494-c3f3541d0843">
                           <id root="7ce11255-d402-4031-a544-dab269eeefb2"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">General Pediatric Dosing Information</content>
                              </paragraph>
                              <paragraph>The GENOTROPIN dosage and administration schedule should be individualized based on the growth response of each patient.</paragraph>
                              <paragraph>Response to somatropin therapy in pediatric patients tends to decrease with time. However, in pediatric patients, the <content styleCode="underline">failure</content> to increase growth rate, particularly during the first year of therapy, indicates the need for close assessment of compliance and evaluation for other causes of growth failure, such as hypothyroidism, undernutrition, advanced bone age and antibodies to recombinant human GH (rhGH).</paragraph>
                              <paragraph>Treatment with GENOTROPIN for short stature should be discontinued when the epiphyses are fused.</paragraph>
                           </text>
                           <effectiveTime value="20240823"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_4b4dd124-9e75-4c28-a083-35b7e130a8cb">
                           <id root="864642cf-82d4-41f3-ac68-d858624f4963"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Pediatric Growth Hormone Deficiency (GHD)</content>
                              </paragraph>
                              <paragraph>Generally, a dose of 0.16 to 0.24 mg/kg body weight/week is recommended.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_1eb61aa5-909f-481f-b22a-1a6fed3c0e1a">
                           <id root="a185bd13-4681-4955-9c7a-6fde52bf0551"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Prader-Willi Syndrome</content>
                              </paragraph>
                              <paragraph>Generally, a dose of 0.24 mg/kg body weight/week is recommended.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_9f44625f-189a-45ad-8917-4f56e3d2de64">
                           <id root="138140de-501a-4322-9dfe-ed1e224afe63"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Turner Syndrom</content>e</paragraph>
                              <paragraph>Generally, a dose of 0.33 mg/kg body weight/week is recommended.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_4d660f65-c9f5-4e4a-b31e-2f724ff9c6a1">
                           <id root="9123c9e7-1bf0-4faa-b58d-09f25f4593d3"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Idiopathic Short Stature</content>
                              </paragraph>
                              <paragraph>Generally, a dose up to 0.47 mg/kg body weight/week is recommended.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_4f1e0405-0ede-4b5e-b854-27f26e80b33e">
                           <id root="2e25bae8-8d41-470b-a408-8e4be5c3170c"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Small for Gestational Age</content>
                                 <footnote>Recent literature has recommended initial treatment with larger doses of somatropin (e.g., 0.48 mg/kg/week), especially in very short children (i.e., height SDS &lt;â3), and/or older/ pubertal children, and that a reduction in dosage (e.g., gradually towards 0.24 mg/kg/week) should be considered if substantial catch-up growth is observed during the first few years of therapy. On the other hand, in younger SGA children (e.g., approximately &lt;4 years) (who respond the best in general) with less severe short stature (i.e., baseline height SDS values between -2 and -3), consideration should be given to initiating treatment at a lower dose (e.g., 0.24 mg/kg/week), and titrating the dose as needed over time. In all children, clinicians should carefully monitor the growth response, and adjust the somatropin dose as necessary.</footnote>
                              </paragraph>
                              <paragraph>Generally, a dose of up to 0.48 mg/kg body weight/week is recommended.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S2.2">
                     <id root="4bf3944a-bba9-423f-b8e5-9aa76d270bcb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2	Dosing of Adult Patients</title>
                     <effectiveTime value="20190401"/>
                     <component>
                        <section ID="ID_6785b77b-4959-4f86-b56a-f8fc6647e855">
                           <id root="d9e347f6-36bb-48e3-9dfd-c055cfbc1e56"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Adult Growth Hormone Deficiency (GHD)</content>
                              </paragraph>
                              <paragraph>Either of two approaches to GENOTROPIN dosing may be followed: a non-weight based regimen or a weight based regimen.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                           <component>
                              <section ID="ID_fa9f984a-35d2-4ca4-b398-e09fe6234443">
                                 <id root="f97e31fd-758e-431d-a86e-301685a5fb05"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="underline">Non-weight based </content>â based on published consensus guidelines, a starting dose of approximately 0.2 mg/day (range, 0.15â0.30 mg/day) may be used without consideration of body weight. This dose can be increased gradually every 1â2 months by increments of approximately 0.1â0.2 mg/day, according to individual patient requirements based on the clinical response and serum insulin-like growth factor I (IGF-I) concentrations. The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range. Maintenance dosages vary considerably from person to person, and between male and female patients.</paragraph>
                                 </text>
                                 <effectiveTime value="20190401"/>
                              </section>
                           </component>
                           <component>
                              <section ID="ID_284dafbe-94c8-4604-95e9-5783fa5cb890">
                                 <id root="763d75b1-595b-4fa4-8f25-ec43c1f4522f"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="underline">Weight based </content>â based on the dosing regimen used in the original adult GHD registration trials, the recommended dosage at the start of treatment is not more than 0.04 mg/kg/week. The dose may be increased according to individual patient requirements to not more than 0.08 mg/kg/week at 4â8 week intervals. Clinical response, side effects, and determination of age- and gender-adjusted serum IGF-I concentrations should be used as guidance in dose titration.</paragraph>
                                    <paragraph>A lower starting dose and smaller dose increments should be considered for older patients, who are more prone to the adverse effects of somatropin than younger individuals. In addition, obese individuals are more likely to manifest adverse effects when treated with a weight-based regimen. In order to reach the defined treatment goal, estrogen-replete women may need higher doses than men. Oral estrogen administration may increase the dose requirements in women.</paragraph>
                                 </text>
                                 <effectiveTime value="20190401"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S2.3">
                     <id root="01acea9a-bbdd-4733-a3f5-4d85b2fc97e8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.3	Preparation and Administration</title>
                     <text>
                        <paragraph>The GENOTROPIN 5 and 12 mg cartridges are color-coded to help ensure proper use with the GENOTROPIN PEN delivery device. The 5 mg cartridge has a green tip to match the green pen window on the Pen 5, while the 12 mg cartridge has a purple tip to match the purple pen window on the Pen 12.</paragraph>
                        <paragraph>Parenteral drug products should always be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. GENOTROPIN MUST NOT BE INJECTED if the solution is cloudy or contains particulate matter. Use it only if it is clear and colorless.</paragraph>
                        <paragraph>GENOTROPIN may be given in the thigh, buttocks, or abdomen; the site of SC injections should be rotated daily to help prevent lipoatrophy.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S3">
               <id root="1e4950be-bc17-43e9-86ea-99dea96fd535"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3	DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>GENOTROPIN is a white, lyophilized powder available as:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>For injection: 5 mg or 12 mg in a single-patient-use two-chamber cartridge</item>
                     <item>
                        <caption>â¢</caption>For injection: 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, or 2 mg in a singleâdose Growth Hormone Delivery Device containing a two-chamber cartridge (GENOTROPIN MINIQUICK)</item>
                  </list>
               </text>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>For injection: 5 mg or 12 mg lyophilized powder in a singleâpatientâuse twoâchamber cartridge (<linkHtml href="#S3">3</linkHtml>)</paragraph>
                        <paragraph>For injection: 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8Â mg, or 2 mg lyophilized powder in a single-dose Growth Hormone Delivery Device containing a two-chamber cartridge (GENOTROPIN MINIQUICK) (<linkHtml href="#S3">3</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S4">
               <id root="508ba7ee-9392-4a4b-919a-688048870885"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4	CONTRAINDICATIONS</title>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Acute Critical Illness (<linkHtml href="#S4">4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Children with Prader-Willi syndrome who are severely obese or have severe respiratory impairment â reports of sudden death (<linkHtml href="#S4">4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Active Malignancy (<linkHtml href="#S4">4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Hypersensitivity to somatropin or excipients (<linkHtml href="#S4">4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Active Proliferative or Severe Non-Proliferative Diabetic Retinopathy (<linkHtml href="#S4">4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Children with closed epiphyses (<linkHtml href="#S4">4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_f4f12de3-272e-4806-bda3-5bd12f289d37">
                     <id root="75147d92-c094-463c-9573-520a4377aa8c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>GENOTROPIN is contraindicated in patients with:</paragraph>
                        <paragraph>â¢<content styleCode="bold"> Acute Critical Illness</content>
                        </paragraph>
                        <paragraph>Treatment with pharmacologic amounts of somatropin is contraindicated in patients with acute critical illness due to complications following open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_ffdc51cc-2fd9-4355-ad12-1e831080b54f">
                     <id root="81bb5ab9-1d95-4f47-881b-e01167adf848"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>â¢<content styleCode="bold"> Prader-Willi Syndrome in Children</content>
                        </paragraph>
                        <paragraph>Somatropin is contraindicated in patients with Prader-Willi syndrome who are severely obese, have a history of upper airway obstruction or sleep apnea, or have severe respiratory impairment. There have been reports of sudden death when somatropin was used in such patients <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_aa67feba-e399-4225-9159-1fe632aab263">
                     <id root="48f860e3-73e7-47dd-8f04-1adf3b1aeab6"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>â¢<content styleCode="bold"> Active Malignancy</content>
                        </paragraph>
                        <paragraph>In general, somatropin is contraindicated in the presence of active malignancy. Any preexisting malignancy should be inactive and its treatment complete prior to instituting therapy with somatropin. Somatropin should be discontinued if there is evidence of recurrent activity. Since growth hormone deficiency may be an early sign of the presence of a pituitary tumor (or, rarely, other brain tumors), the presence of such tumors should be ruled out prior to initiation of treatment. Somatropin should not be used in patients with any evidence of progression or recurrence of an underlying intracranial tumor.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_36d1248b-3346-4eaa-a528-f3a48cb37863">
                     <id root="3333c7fb-0fff-4942-8af1-35e35cbf1a46"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>â¢<content styleCode="bold"> Hypersensitivity</content>
                        </paragraph>
                        <paragraph>GENOTROPIN is contraindicated in patients with a known hypersensitivity to somatropin or any of its excipients. The 5 mg and 12 mg presentations of GENOTROPIN lyophilized powder contain m-cresol as a preservative. Systemic hypersensitivity reactions have been reported with postmarketing use of somatropins <content styleCode="italics">[see <linkHtml href="#S5.6">Warnings and Precautions (5.6)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_0d9b707a-5032-449f-8e15-fe5db8fd905e">
                     <id root="8a599462-6e9f-4635-aa51-9ccb5adcba73"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>â¢ <content styleCode="bold">Diabetic Retinopathy</content>
                        </paragraph>
                        <paragraph>Somatropin is contraindicated in patients with active proliferative or severe non-proliferative diabetic retinopathy.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_e3a63059-b9ed-4891-aa5a-c545855f8d95">
                     <id root="dfc77975-611a-4469-a64d-24ecffd409fa"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>â¢ <content styleCode="bold">Closed Epiphyses</content>
                        </paragraph>
                        <paragraph>Somatropin should not be used for growth promotion in pediatric patients with closed epiphyses.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S5">
               <id root="7f4010d3-3eb8-4c72-b4dc-e5cf962f1244"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5	WARNINGS AND PRECAUTIONS</title>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Acute Critical Illness: Potential benefit of treatment continuation should be weighed against the potential risk (<linkHtml href="#S5.1">5.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Prader-Willi Syndrome in Children: Evaluate for signs of upper airway obstruction and sleep apnea before initiation of treatment<br/>Discontinue treatment if these signs occur (<linkHtml href="#S5.2">5.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Neoplasm: Monitor patients with preexisting tumors for progression or recurrence. Increased risk of a second neoplasm in childhood cancer survivors treated with somatropin in particular meningiomas in patients treated with radiation to the head for their first neoplasm (<linkHtml href="#S5.3">5.3</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Impaired Glucose Tolerance and Diabetes Mellitus: May be unmasked<br/>Periodically monitor glucose levels in all patients. Doses of concurrent antihyperglycemic drugs in diabetics may require adjustment (<linkHtml href="#S5.4">5.4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Intracranial Hypertension: Exclude preexisting papilledema. May develop and is usually reversible after discontinuation or dose reduction (<linkHtml href="#S5.5">5.5</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Hypersensitivity: Serious hypersensitivity reactions may occur. In the event of an allergic reaction, seek prompt medical attention (<linkHtml href="#S5.6">5.6</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Fluid Retention (i.e., edema, arthralgia, carpal tunnel syndrome â especially in adults): May occur frequently. Reduce dose as necessary (<linkHtml href="#S5.7">5.7</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Hypoadrenalism: Monitor patients for reduced serum cortisol levels and/or need for glucocorticoid dose increases in those with known hypoadrenalism (<linkHtml href="#S5.8">5.8</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Hypothyroidism: May first become evident or worsen. Monitor thyroid function periodically (<linkHtml href="#S5.9">5.9</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Slipped Capital Femoral Epiphysis: May develop. Evaluate children with the onset of a limp or hip/knee pain (<linkHtml href="#S5.10">5.10</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Progression of Preexisting Scoliosis: Monitor any child with scoliosis for progression of the curve (<linkHtml href="#S5.11">5.11</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Pancreatitis: Consider pancreatitis in patients with persistent severe abdominal pain (<linkHtml href="#S5.15">5.15</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S5.1">
                     <id root="cbd621a2-463a-458b-9459-4dd39303c643"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1	Acute Critical Illness</title>
                     <text>
                        <paragraph>Increased mortality in patients with acute critical illness due to complications following open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure has been reported after treatment with <content styleCode="underline">pharmacologic</content> amounts of somatropin <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>].</content> Two placebo-controlled clinical trials in non-growth hormone deficient adult patients (n=522) with these conditions in intensive care units revealed a significant increase in mortality (42% vs. 19%) among somatropin-treated patients (doses 5.3â8 mg/day) compared to those receiving placebo. The safety of continuing somatropin treatment in patients receiving <content styleCode="underline">replacement</content> doses for approved indications who concurrently develop these illnesses has not been established. Therefore, the potential benefit of treatment continuation with somatropin in patients having acute critical illnesses should be weighed against the potential risk.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.2">
                     <id root="ee84cac7-730f-4f56-8527-5469485719d2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2	Prader-Willi Syndrome in Children</title>
                     <text>
                        <paragraph>There have been reports of fatalities after initiating therapy with somatropin in pediatric patients with Prader-Willi syndrome who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnea, or unidentified respiratory infection. Male patients with one or more of these factors may be at greater risk than females. Patients with Prader-Willi syndrome should be evaluated for signs of upper airway obstruction and sleep apnea before initiation of treatment with somatropin. If during treatment with somatropin, patients show signs of upper airway obstruction (including onset of or increased snoring) and/or new onset sleep apnea, treatment should be interrupted. All patients with Prader-Willi syndrome treated with somatropin should also have effective weight control and be monitored for signs of respiratory infection, which should be diagnosed as early as possible and treated aggressively <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.3">
                     <id root="1432164a-167a-4dd5-9605-68c6cc512f86"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3	Neoplasms</title>
                     <text>
                        <paragraph>In childhood cancer survivors who were treated with radiation to the brain/head for their first neoplasm and who developed subsequent GHD and were treated with somatropin, an increased risk of a second neoplasm has been reported. Intracranial tumors, in particular meningiomas, were the most common of these second neoplasms. In adults, it is unknown whether there is any relationship between somatropin replacement therapy and CNS tumor recurrence <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>]</content>. </paragraph>
                        <paragraph>Monitor all patients with a history of GHD secondary to an intracranial neoplasm routinely while on somatropin therapy for progression or recurrence of the tumor. </paragraph>
                        <paragraph>Because children with certain rare genetic causes of short stature have an increased risk of developing malignancies, practitioners should thoroughly consider the risks and benefits of starting somatropin in these patients. If treatment with somatropin is initiated, these patients should be carefully monitored for development of neoplasms.<br/>
                        </paragraph>
                        <paragraph>Monitor patients on somatropin therapy carefully for increased growth, or potential malignant changes, of preexisting nevi.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.4">
                     <id root="d431e478-2adf-4b0f-b81f-0aa27b144fbe"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4	Impaired Glucose Tolerance and Diabetes Mellitus</title>
                     <text>
                        <paragraph>Treatment with somatropin may decrease insulin sensitivity, particularly at higher doses in susceptible patients. As a result, previously undiagnosed impaired glucose tolerance and overt diabetes mellitus may be unmasked during somatropin treatment. New-onset Type 2 diabetes mellitus has been reported. Therefore, glucose levels should be monitored periodically in all patients treated with somatropin, especially in those with risk factors for diabetes mellitus, such as obesity, Turner syndrome, or a family history of diabetes mellitus. Patients with preexisting type 1 or type 2 diabetes mellitus or impaired glucose tolerance should be monitored closely during somatropin therapy. The doses of antihyperglycemic drugs (i.e., insulin or oral/injectable agents) may require adjustment when somatropin therapy is instituted in these patients.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.5">
                     <id root="6b57328c-bc3a-400a-af33-5a9d9392165e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5 Intracranial Hypertension</title>
                     <text>
                        <paragraph>Intracranial hypertension (IH) with papilledema, visual changes, headache, nausea and/or vomiting has been reported in a small number of patients treated with somatropins. Symptoms usually occurred within the first eight (8) weeks after the initiation of somatropin therapy. In all reported cases, IH-associated signs and symptoms rapidly resolved after cessation of therapy or a reduction of the somatropin dose. Fundoscopic examination should be performed routinely before initiating treatment with somatropin to exclude preexisting papilledema, and periodically during the course of somatropin therapy. If papilledema is observed by fundoscopy during somatropin treatment, treatment should be stopped. If somatropin-induced IH is diagnosed, treatment with somatropin can be restarted at a lower dose after IH-associated signs and symptoms have resolved. Patients with Turner syndrome and Prader-Willi syndrome may be at increased risk for the development of IH.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.6">
                     <id root="2939c43f-7cf1-4b42-bc92-ea01a3774caa"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6	Severe Hypersensitivity</title>
                     <text>
                        <paragraph>Serious systemic hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with postmarketing use of somatropins. Patients and caregivers should be informed that such reactions are possible and that prompt medical attention should be sought if an allergic reaction occurs <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.7">
                     <id root="4502c235-7031-4fa8-beac-3a6c1cd0326e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.7	Fluid Retention</title>
                     <text>
                        <paragraph>Fluid retention during somatropin replacement therapy in adults may occur. Clinical manifestations of fluid retention (e.g., edema, arthralgia, myalgia, nerve compression syndromes including carpal tunnel syndrome/paresthesia) are usually transient and dose dependent.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.8">
                     <id root="884763d3-c61e-4aba-9830-33d2d617c9b7"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.8	Hypoadrenalism</title>
                     <text>
                        <paragraph>Patients receiving somatropin therapy who have or are at risk for pituitary hormone deficiency(s) may be at risk for reduced serum cortisol levels and/or unmasking of central (secondary) hypoadrenalism. In addition, patients treated with glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in their maintenance or stress doses following initiation of somatropin treatment <content styleCode="italics">[see <linkHtml href="#S7.1">Drug Interactions (7.1)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.9">
                     <id root="96917f1e-b9e4-43e6-ab05-21b3a3bc0120"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.9 Hypothyroidism</title>
                     <text>
                        <paragraph>Undiagnosed/untreated hypothyroidism may prevent an optimal response to somatropin, in particular, the growth response in children. Patients with Turner syndrome have an inherently increased risk of developing autoimmune thyroid disease and primary hypothyroidism. In patients with growth hormone deficiency, central (secondary) hypothyroidism may first become evident or worsen during somatropin treatment. Therefore, patients treated with somatropin should have periodic thyroid function tests and thyroid hormone replacement therapy should be initiated or appropriately adjusted when indicated.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.10">
                     <id root="1e9226c1-3ab8-4f8a-8a93-46fedd3f2744"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.10	Slipped Capital Femoral Epiphyses in Pediatric Patients</title>
                     <text>
                        <paragraph>Slipped capital femoral epiphyses may occur more frequently in patients with endocrine disorders (including GHD and Turner syndrome) or in patients undergoing rapid growth. Any pediatric patient with the onset of a limp or complaints of hip or knee pain during somatropin therapy should be carefully evaluated.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.11">
                     <id root="8f76c81b-d201-48cf-a68d-633c43f2fecc"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.11	Progression of Preexisting Scoliosis in Pediatric Patients</title>
                     <text>
                        <paragraph>Progression of scoliosis can occur in patients who experience rapid growth. Because somatropin increases growth rate, patients with a history of scoliosis who are treated with somatropin should be monitored for progression of scoliosis. However, somatropin has not been shown to increase the occurrence of scoliosis. Skeletal abnormalities including scoliosis are commonly seen in untreated Turner syndrome patients. Scoliosis is also commonly seen in untreated patients with Prader-Willi syndrome. Physicians should be alert to these abnormalities, which may manifest during somatropin therapy.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.12">
                     <id root="774dbce3-2812-42c1-86b6-48c274348d63"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.12 	Otitis Media and Cardiovascular Disorders in Turner Syndrome</title>
                     <text>
                        <paragraph>Patients with Turner syndrome should be evaluated carefully for otitis media and other ear disorders since these patients have an increased risk of ear and hearing disorders. Somatropin treatment may increase the occurrence of otitis media in patients with Turner syndrome. In addition, patients with Turner syndrome should be monitored closely for cardiovascular disorders (e.g., stroke, aortic aneurysm/dissection, hypertension) as these patients are also at risk for these conditions.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.13">
                     <id root="e8d23561-a5c1-40d6-80cf-a8a1a2d7f5ea"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.13	 Lipoatrophy</title>
                     <text>
                        <paragraph>When somatropin is administered subcutaneously at the same site over a long period of time, tissue atrophy may result. This can be avoided by rotating the injection site <content styleCode="italics">[see <linkHtml href="#S2.3">Dosage and Administration (2.3)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.14">
                     <id root="5948a04c-e28c-48d7-842c-04f429a6f3a3"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.14 	Laboratory Tests</title>
                     <text>
                        <paragraph>Serum levels of inorganic phosphorus, alkaline phosphatase, parathyroid hormone (PTH) and IGF-I may increase during somatropin therapy.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.15">
                     <id root="28290f72-8d94-4734-b177-cf3562495a6f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.15	Pancreatitis</title>
                     <text>
                        <paragraph>Cases of pancreatitis have been reported rarely in children and adults receiving somatropin treatment, with some evidence supporting a greater risk in children compared with adults. Published literature indicates that girls who have Turner syndrome may be at greater risk than other somatropin-treated children. Pancreatitis should be considered in any somatropinâtreated patient, especially a child, who develops persistent severe abdominal pain.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S6">
               <id root="e9cb768d-7c01-4f60-a2c8-59fa670115a6"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6	ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following important adverse reactions are also described elsewhere in the labeling:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Increased mortality in patients with acute critical illness <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Fatalities in children with Prader-Willi syndrome <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Neoplasms <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Glucose intolerance and diabetes mellitus <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Intracranial hypertension <content styleCode="italics">[see <linkHtml href="#S5.5">Warnings and Precautions (5.5)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Severe hypersensitivity <content styleCode="italics">[see <linkHtml href="#S5.6">Warnings and Precautions (5.6)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Fluid retention <content styleCode="italics">[see <linkHtml href="#S5.7">Warnings and Precautions (5.7)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Hypoadrenalism <content styleCode="italics">[see <linkHtml href="#S5.8">Warnings and Precautions (5.8)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Hypothyroidism <content styleCode="italics">[see <linkHtml href="#S5.9">Warnings and Precautions (5.9)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Slipped capital femoral epiphysis in pediatric patients <content styleCode="italics">[see <linkHtml href="#S5.10">Warnings and Precautions (5.10)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Progression of preexisting scoliosis in pediatric patients <content styleCode="italics">[see <linkHtml href="#S5.11">Warnings and Precautions (5.11)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Otitis media and cardiovascular disorders in patients with Turner syndrome <content styleCode="italics">[see <linkHtml href="#S5.12">Warnings and Precautions (5.12)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Lipoatrophy <content styleCode="italics">[see <linkHtml href="#S5.13">Warnings and Precautions (5.13)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Pancreatitis <content styleCode="italics">[see <linkHtml href="#S5.15">Warnings and Precautions (5.15)</linkHtml>]</content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Other common somatropin-related adverse reactions include injection site reactions/rashes and lipoatrophy (<linkHtml href="#S6.1">6.1</linkHtml>) and headaches (<linkHtml href="#S6.2">6.2</linkHtml>).</paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or <linkHtml href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program">www.fda.gov/medwatch</linkHtml>.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S6.1">
                     <id root="c766ff26-982a-4e4b-ae8a-518ad8f85df3"/>
                     <code code="90374-0" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL TRIALS EXPERIENCE SECTION"/>
                     <title>6.1	Clinical Trials Experience</title>
                     <text>
                        <paragraph>Because clinical trials are conducted under varying conditions, adverse reaction rates observed during the clinical trials performed with one somatropin formulation cannot always be directly compared to the rates observed during the clinical trials performed with a second somatropin formulation, and may not reflect the adverse reaction rates observed in practice.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_9b8357aa-7651-4983-b6c9-ca06afc23536">
                           <id root="251cd54b-deac-438f-bd62-f4ecc8f60718"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in children with GHD</content>
                              </paragraph>
                              <paragraph>In clinical studies with GENOTROPIN in pediatric GHD patients, the following events were reported infrequently: injection site reactions, including pain or burning associated with the injection, fibrosis, nodules, rash, inflammation, pigmentation, or bleeding; lipoatrophy; headache; hematuria; hypothyroidism; and mild hyperglycemia.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_66300264-99c3-4d5c-9c84-93e139cac7a2">
                           <id root="60506514-c439-46a0-835f-ac7b0dd7880f"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in PWS </content>
                              </paragraph>
                              <paragraph>In two clinical studies with GENOTROPIN in pediatric patients with Prader-Willi syndrome, the following drug-related events were reported: edema, aggressiveness, arthralgia, benign intracranial hypertension, hair loss, headache, and myalgia.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_773b3ce0-fe78-43b8-bd08-896c4ebb978a">
                           <id root="b7f2e75a-e838-465f-bf6e-b6d978a8c3e3"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in children with SGA</content>
                              </paragraph>
                              <paragraph>In clinical studies of 273 pediatric patients born small for gestational age treated with GENOTROPIN, the following clinically significant events were reported: mild transient hyperglycemia, one patient with benign intracranial hypertension, two patients with central precocious puberty, two patients with jaw prominence, and several patients with aggravation of preexisting scoliosis, injection site reactions, and self-limited progression of pigmented nevi. Anti-hGH antibodies were not detected in any of the patients treated with GENOTROPIN.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_97cdf842-5148-4bf1-b0bd-19eda4388535">
                           <id root="f165c2a2-38a6-4886-9683-21a8881937fb"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in children with Turner Syndrome </content>
                              </paragraph>
                              <paragraph>In two clinical studies with GENOTROPIN in pediatric patients with Turner syndrome, the most frequently reported adverse events were respiratory illnesses (influenza, tonsillitis, otitis, sinusitis), joint pain, and urinary tract infection. The only treatment-related adverse event that occurred in more than 1 patient was joint pain.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_e2fda63f-b15f-4ff8-9d18-1c88c392b949">
                           <id root="fa91c4a8-524e-4b9b-af36-6a0a85a37c6b"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in children with Idiopathic Short Stature</content>
                              </paragraph>
                              <paragraph>In two open-label clinical studies with GENOTROPIN in pediatric patients with ISS, the most commonly encountered adverse events include upper respiratory tract infections, influenza, tonsillitis, nasopharyngitis, gastroenteritis, headaches, increased appetite, pyrexia, fracture, altered mood, and arthralgia. In one of the two studies, during GENOTROPIN treatment, the mean IGF-1 standard deviation (SD) scores were maintained in the normal range. IGF-1 SD scores above +2 SD were observed as follows: 1 subject (3%), 10 subjects (30%) and 16 subjects (38%) in the untreated control, 0. 23 and the 0.47 mg/kg/week groups, respectively, had at least one measurement; while 0 subjects (0%), 2 subjects (7%) and 6 subjects (14%) had two or more consecutive IGF-1 measurements above +2 SD.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_a8717764-e744-41a7-b50d-7c5fae01e846">
                           <id root="19820c50-2318-43f2-99c0-2cf81940240b"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Clinical Trials in adults with GHD</content>
                              </paragraph>
                              <paragraph>In clinical trials with GENOTROPIN in 1,145 GHD adults, the majority of the adverse events consisted of mild to moderate symptoms of fluid retention, including peripheral swelling, arthralgia, pain and stiffness of the extremities, peripheral edema, myalgia, paresthesia, and hypoesthesia. These events were reported early during therapy and tended to be transient and/or responsive to dosage reduction.</paragraph>
                              <paragraph>Table 1 displays the adverse events reported by 5% or more of adult GHD patients in clinical trials after various durations of treatment with GENOTROPIN. Also presented are the corresponding incidence rates of these adverse events in placebo patients during the 6-month double-blind portion of the clinical trials.</paragraph>
                              <table ID="_Reftable1" width="75%">
                                 <caption>Table 1. Adverse Events Reported by â¥ 5% of 1,145 Adult GHD Patients During Clinical Trials of GENOTROPIN and Placebo, Grouped by Duration of Treatment</caption>
                                 <col width="19%"/>
                                 <col width="12%"/>
                                 <col width="17%"/>
                                 <col width="12%"/>
                                 <col width="12%"/>
                                 <col width="12%"/>
                                 <thead>
                                    <tr>
                                       <th align="left" styleCode="Rrule Toprule " valign="top"/>
                                       <th align="center" colspan="2" styleCode="Rrule Toprule " valign="top">Double Blind Phase</th>
                                       <th align="center" colspan="3" styleCode="Toprule " valign="top">Open Label Phase<br/>GENOTROPIN</th>
                                    </tr>
                                    <tr>
                                       <th align="left" styleCode="Rrule Botrule " valign="top">Adverse Event</th>
                                       <th align="center" styleCode="Rrule Botrule " valign="bottom">Placebo<br/>0â6 mo.<br/>n = 572<br/>% Patients</th>
                                       <th align="center" styleCode="Rrule Botrule " valign="bottom">GENOTROPIN<br/>0â6 mo.<br/>n = 573<br/>% Patients</th>
                                       <th align="center" styleCode="Rrule Botrule " valign="bottom">6â12 mo.<br/>n = 504<br/>% Patients</th>
                                       <th align="center" styleCode="Rrule Botrule " valign="bottom">12â18 mo.<br/>n = 63<br/>% Patients</th>
                                       <th align="center" styleCode="Botrule " valign="bottom">18â24 mo.<br/>n = 60<br/>% Patients</th>
                                    </tr>
                                 </thead>
                                 <tfoot>
                                    <tr>
                                       <td align="left" colspan="6" valign="top">n = number of patients receiving treatment during the indicated period.<br/> %= percentage of patients who reported the event during the indicated period. </td>
                                    </tr>
                                 </tfoot>
                                 <tbody>
                                    <tr>
                                       <td styleCode="Rrule Toprule " valign="top">
                                          <paragraph>Swelling, peripheral</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule " valign="top">
                                          <paragraph>5.1</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule " valign="top">
                                          <paragraph>17.5<footnote ID="_Ref175602569">Increased significantly when compared to placebo, <content styleCode="italics">P</content>â¤.025: FisherÂ´s Exact Test (one-sided)</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule " valign="top">
                                          <paragraph>5.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule " valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Toprule " valign="top">
                                          <paragraph>1.7</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Arthralgia</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>4.2</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>17.3<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>6.9</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>6.3</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>3.3</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Upper respiratory infection</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>14.5</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>15.5</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>13.1</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>15.9</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>13.3</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Pain, extremities</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>5.9</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>14.7<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>6.7</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>1.6</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>3.3</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Edema, peripheral</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>2.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>10.8<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>3.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Paresthesia</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>1.9</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>9.6<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>2.2</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>3.2</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Headache</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>7.7</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>9.9</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>6.2</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Stiffness of extremities</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>1.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>7.9<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>2.4</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>1.6</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Fatigue</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>3.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>5.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>4.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>6.3</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>1.7</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Myalgia</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>1.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>4.9<footnoteRef IDREF="_Ref175602569"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>2.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>4.8</paragraph>
                                       </td>
                                       <td align="center" valign="top">
                                          <paragraph>6.7</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Botrule " valign="top">
                                          <paragraph>Back pain</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>4.4</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>2.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>3.4</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>4.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Botrule " valign="top">
                                          <paragraph>5.0</paragraph>
                                       </td>
                                    </tr>
                                 </tbody>
                              </table>
                           </text>
                           <effectiveTime value="20240823"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_dc51faec-5847-476d-b285-46a7ed7f1208">
                           <id root="04b50418-817b-4f6d-aff3-43ea0d8f0513"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Post-Trial Extension Studies in Adults</content>
                              </paragraph>
                              <paragraph>In expanded post-trial extension studies, diabetes mellitus developed in 12 of 3,031 patients (0.4%) during treatment with GENOTROPIN. All 12 patients had predisposing factors, e.g., elevated glycated hemoglobin levels and/or marked obesity, prior to receiving GENOTROPIN. Of the 3,031 patients receiving GENOTROPIN, 61 (2%) developed symptoms of carpal tunnel syndrome, which lessened after dosage reduction or treatment interruption (52) or surgery (9). Other adverse events that have been reported include generalized edema and hypoesthesia.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_a6a41ecb-a19c-4192-9fb7-0d194e879c6b">
                           <id root="8f79a14e-53a5-4fd3-be6f-96349ecb7d59"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Periplasmic Escherichia coli Peptides </content>
                              </paragraph>
                              <paragraph>Preparations of GENOTROPIN contain a small amount of periplasmic <content styleCode="italics">Escherichia coli</content> peptides (PECP). Anti-PECP antibodies are found in a small number of patients treated with GENOTROPIN, but these appear to be of no clinical significance.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S6.2">
                     <id root="bd0136c1-9b82-4354-82a3-f2ab4da678e8"/>
                     <code code="90375-7" codeSystem="2.16.840.1.113883.6.1" displayName="POSTMARKETING EXPERIENCE SECTION"/>
                     <title>6.2	Postmarketing Experience</title>
                     <text>
                        <paragraph>Because these adverse events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
                        <paragraph>Serious systemic hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with postmarketing use of somatropins <content styleCode="italics">[see <linkHtml href="#S5.6">Warnings and Precautions (5.6)</linkHtml>].</content>
                        </paragraph>
                        <paragraph>Leukemia has been reported in a small number of GHD children treated with somatropin, somatrem (methionylated rhGH) and GH of pituitary origin. It is uncertain whether these cases of leukemia are related to GH therapy, the pathology of GHD itself, or other associated treatments such as radiation therapy. On the basis of current evidence, experts have not been able to conclude that GH therapy <content styleCode="italics">per se</content> was responsible for these cases of leukemia. The risk for children with GHD, if any, remains to be established <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml> and <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>].</content>
                        </paragraph>
                        <paragraph>The following serious adverse reactions have been observed with use of somatropin (including events observed in patients who received brands of somatropin other than GENOTROPIN): acute critical illness <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>, sudden death <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>, intracranial tumors <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>, central hypothyroidism <content styleCode="italics">[see <linkHtml href="#S5.9">Warnings and Precautions (5.9)</linkHtml>]</content>, cardiovascular disorders, and pancreatitis <content styleCode="italics">[see <linkHtml href="#S5.15">Warnings and Precautions (5.15)</linkHtml>]</content>.</paragraph>
                        <paragraph>Slipped capital femoral epiphysis and Legg-Calve-Perthes disease (osteonecrosis/avascular necrosis; occasionally associated with slipped capital femoral epiphysis) have been reported in children treated with growth hormone <content styleCode="italics">[see <linkHtml href="#S5.10">Warnings and Precautions (5.10)</linkHtml>].</content> Cases have been reported with GENOTROPIN<content styleCode="italics">.</content>
                        </paragraph>
                        <paragraph>The following additional adverse reactions have been observed during the appropriate use of somatropin: headaches (children and adults), gynecomastia (children), and significant diabetic retinopathy.</paragraph>
                        <paragraph>New-onset type 2 diabetes mellitus has been reported.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S7">
               <id root="22ef24c8-8fe5-47b5-ac43-ef95be2f1824"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7	DRUG INTERACTIONS</title>
               <effectiveTime value="20240823"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Inhibition of 11Ã-Hydroxysteroid Dehydrogenase Type 1: May require the initiation of glucocorticoid replacement therapy. Patients treated with glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in their maintenance doses (<linkHtml href="#S7.1">7.1</linkHtml>, <linkHtml href="#S7.2">7.2</linkHtml>).</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Glucocorticoid Replacement: Should be carefully adjusted (<linkHtml href="#S7.2">7.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Cytochrome P450-Metabolized Drugs: Monitor carefully if used with somatropin (<linkHtml href="#S7.3">7.3</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Oral Estrogen: Larger doses of somatropin may be required in women (<linkHtml href="#S7.4">7.4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Insulin and/or Oral/Injectable Hypoglycemic Agents: May require adjustment (<linkHtml href="#S7.5">7.5</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S7.1">
                     <id root="0c867732-9b68-413a-9d69-f418d91a30d0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.1	11 Î²-Hydroxysteroid Dehydrogenase Type 1</title>
                     <text>
                        <paragraph>The microsomal enzyme 11Î²-hydroxysteroid dehydrogenase type 1 (11Î²HSD-1) is required for conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue. GH and somatropin inhibit 11Î²HSD-1. Consequently, individuals with untreated GH deficiency have relative increases in 11Î²HSD-1 and serum cortisol. Introduction of somatropin treatment may result in inhibition of 11Î²HSD-1 and reduced serum cortisol concentrations. As a consequence, previously undiagnosed central (secondary) hypoadrenalism may be unmasked and glucocorticoid replacement may be required in patients treated with somatropin. In addition, patients treated with glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in their maintenance or stress doses following initiation of somatropin treatment; this may be especially true for patients treated with cortisone acetate and prednisone since conversion of these drugs to their biologically active metabolites is dependent on the activity of 11Î²HSD-1 <content styleCode="italics">[see <linkHtml href="#S5.8">Warnings and Precautions (5.8</linkHtml>)]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S7.2">
                     <id root="ae937a0d-829c-491b-bf22-ae43f4b5b125"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.2	Pharmacologic Glucocorticoid Therapy and Supraphysiologic Glucocorticoid Treatment</title>
                     <text>
                        <paragraph>Pharmacologic glucocorticoid therapy and supraphysiologic glucocorticoid treatment may attenuate the growthâpromoting effects of somatropin in children. Therefore, glucocorticoid replacement dosing should be carefully adjusted in children receiving concomitant somatropin and glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S7.3">
                     <id root="0a9b4636-1e9d-4e99-9246-1704a901ff27"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.3	Cytochrome P450-Metabolized Drugs</title>
                     <text>
                        <paragraph>Limited published data indicate that somatropin treatment increases cytochrome P450 (CYP450)-mediated antipyrine clearance in man. These data suggest that somatropin administration may alter the clearance of compounds known to be metabolized by CYP450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine). Careful monitoring is advisable when somatropin is administered in combination with other drugs known to be metabolized by CYP450 liver enzymes. However, formal drug interaction studies have not been conducted.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S7.4">
                     <id root="1523319c-dfbc-4786-bdee-daea91b58616"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.4	Oral Estrogen</title>
                     <text>
                        <paragraph>In patients on oral estrogen replacement, a larger dose of somatropin may be required to achieve the defined treatment goal <content styleCode="italics">[see <linkHtml href="#S2.2">Dosage and Administration (2.2)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S7.5">
                     <id root="74ef44d0-38bc-4f6a-8217-c39864dc32a9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.5	Insulin and/or Oral/Injectable Hypoglycemic Agents</title>
                     <text>
                        <paragraph>In patients with diabetes mellitus requiring drug therapy, the dose of insulin and/or oral/injectable agent may require adjustment when somatropin therapy is initiated <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S8">
               <id root="96d68340-0b72-4fcb-8fbd-1bbe16aceaac"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8	USE IN SPECIFIC POPULATIONS</title>
               <effectiveTime value="20240823"/>
               <component>
                  <section ID="S8.1">
                     <id root="bdcb0cd3-65bb-4353-b337-fc043442ba53"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1	Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>Limited available data with somatropin use in pregnant women are insufficient to determine a drug-associated risk of adverse developmental outcomes. In animal studies (rats and rabbits), there was no evidence of embryoâfetal or neonatal harm following somatropin administration during organogenesis at doses approximately 24 times and 19 times the recommended human therapeutic levels, respectively, based on body surface area <content styleCode="italics">(</content>see <content styleCode="italics">
                              <linkHtml href="#bkmrk_Data">Data</linkHtml>)</content>. </paragraph>
                        <paragraph>The estimated background risk of birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.</paragraph>
                        <paragraph ID="bkmrk_Data">
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Animal Data</content>
                        </paragraph>
                        <paragraph>Animal reproduction studies with somatropin during the period of organogenesis at doses of 0.3, 1, and 3.3Â mg/kg/day administered subcutaneously (SC) in pregnant rats and 0.08, 0.3, and 1.3Â mg/kg/day administered intramuscularly in pregnant rabbits were not teratogenic (highest doses approximately 24 times and 19 times the recommended human therapeutic levels, respectively, based on body surface area).</paragraph>
                        <paragraph>In perinatal and postnatal studies in rats, somatropin doses of 0.3, 1, and 3.3 mg/kg/day produced growthâpromoting effects in the dams but not in the fetuses. Young rats at the highest dose showed increased weight gain during suckling but the effect was not apparent by 10 weeks of age. No adverse effects were observed on gestation, morphogenesis, parturition, lactation, postnatal development, or reproductive capacity of the offspring due to somatropin.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6fd28e16-725e-49a0-a03b-728c03f4ebe6">
                     <id root="5c7a8bb3-5665-4ab4-8312-bbbb5b81bee6"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.2	Lactation </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>There is no information regarding the presence of somatropin in human milk. Limited published data indicate that exogenous somatropin does not increase normal breastmilk concentrations of growth hormone. No adverse effects related to somatropin in the breastfeed infant have been reported. The developmental and health benefits of breastfeeding should be considered along with the motherâs clinical need for GENOTROPIN and any potential adverse effects on the breastfed infant from GENOTROPIN or from the underlying maternal condition.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_17d48211-44e5-45db-a760-8f9440a6089c">
                     <id root="a2184f47-a116-4e08-bf96-caad3513cc84"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4	Pediatric Use </title>
                     <text>
                        <paragraph>Safety and effectiveness of GENOTROPIN in pediatric patients have been established in growth failure due to Prader-Willi syndrome (PWS), growth failure in children born small for gestational age (SGA) with no catch-up growth by age 2 years, growth failure associated with Turner syndrome, idiopathic short stature (ISS) and growth failure due to inadequate secretion of endogenous growth hormone.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Growth Failure Due to Prader-Willi Syndrome (PWS)</content>
                        </paragraph>
                        <paragraph>Safety and effectiveness of GENOTROPIN have been established in pediatric patients with growth failure due to Prader-Willi syndrome based on data from two randomized, open-label, controlled clinical trials with GENOTROPIN in 43 pediatric patients. There have been reports of sudden death after initiating therapy with somatropin in pediatric patients with Prader-Willi syndrome who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnea, or unidentified respiratory infection. Male patients with one or more of these factors may be at greater risk than females. Patients with Prader-Willi syndrome should be evaluated for signs of upper airway obstruction and sleep apnea before initiation of treatment with somatropin <content styleCode="italics">[see <linkHtml href="#S4">Contraindications (4)</linkHtml>, <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>, <linkHtml href="#ID_6e0def5e-a0ae-4889-ad76-e100379045cb">Clinical Studies (14.2)</linkHtml>]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Short Stature in Pediatric Patients Born Small for Gestational Age (SGA) with No Catch-up Growth by Age 2</content>
                        </paragraph>
                        <paragraph>Safety and effectiveness of GENOTROPIN have been established in pediatric patients with short stature born SGA with no catch-up growth based on data from 4 randomized, open-label, controlled clinical trials with GENOTROPIN in 209 pediatric patients <content styleCode="italics">[see <linkHtml href="#ID_6cb41885-b3a2-4b0e-9035-621d29e90cc7">Clinical Studies (14.3)</linkHtml>]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Short Stature associated with Turner Syndrome</content>
                        </paragraph>
                        <paragraph>Safety and effectiveness of GENOTROPIN have been established in pediatric patients with short stature associated with Turner syndrome based on data from two randomized, open-label, clinical trials with GENOTROPIN in 38 pediatric patients <content styleCode="italics">[see <linkHtml href="#ID_1ad9e8dc-5dfb-40f7-bccf-5d7392fbf260">Clinical Studies (14.4)</linkHtml>].</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Idiopathic Short Stature (ISS)</content>
                        </paragraph>
                        <paragraph>Safety and effectiveness of GENOTROPIN have been established in pediatric patients with ISS based on data from one randomized, open-label, clinical trial with GENOTROPIN in 102 pediatric patients <content styleCode="italics">[see <linkHtml href="#ID_b5e881d3-c8b2-4d30-8832-800030522437">Clinical Studies (14.5)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.5">
                     <id root="0496d2f8-2815-43c2-bf2b-17984b9a12f7"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5	Geriatric Use</title>
                     <text>
                        <paragraph>The safety and effectiveness of GENOTROPIN in patients aged 65 and over have not been evaluated in clinical studies. Elderly patients may be more sensitive to the action of GENOTROPIN, and therefore may be more prone to develop adverse reactions. A lower starting dose and smaller dose increments should be considered for older patients <content styleCode="italics">[see <linkHtml href="#S2.2">Dosage and Administration (2.2)</linkHtml>]. </content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S10">
               <id root="dd76443c-b392-43ff-8710-5836e2ed75ab"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10	OVERDOSAGE</title>
               <text>
                  <paragraph>
                     <content styleCode="italics">Short-Term</content>
                  </paragraph>
                  <paragraph>Short-term overdosage could lead initially to hypoglycemia and subsequently to hyperglycemia. Furthermore, overdose with somatropin is likely to cause fluid retention.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Long-Term</content>
                  </paragraph>
                  <paragraph>Long-term overdosage could result in signs and symptoms of gigantism and/or acromegaly consistent with the known effects of excess growth hormone <content styleCode="italics">[see <linkHtml href="#S2">Dosage and Administration (2)</linkHtml>].</content>
                  </paragraph>
               </text>
               <effectiveTime value="20240823"/>
            </section>
         </component>
         <component>
            <section ID="S11">
               <id root="76457abf-2ec6-4283-b384-c59dc7bf60ac"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11	DESCRIPTION</title>
               <text>
                  <paragraph>Somatropin is a human growth hormone produced by recombinant DNA technology in Escherichia coli. The protein is comprised of 191 amino acid residues and has a molecular weight of 22,124Â daltons. The amino acid sequence is identical to that of human growth hormone of pituitary origin.</paragraph>
                  <paragraph>GENOTROPIN (somatropin) for injection is a sterile, white, lyophilized powder in a single-patient-use or single-dose, two-chamber cartridge intended for subcutaneous injection after reconstitution. The front chamber contains somatropin and the rear chamber contains diluent.</paragraph>
                  <paragraph>GENOTROPIN 5 mg is a single-patient-use, two-chamber cartridge. GENOTROPIN 5 mg is designed for use with a reusable device (GENOTROPIN PEN 5) for product reconstitution and drug delivery. After reconstitution, each mL contains 5Â mg of somatropin, dibasic sodium phosphate (0.27 mg), glycine (2 mg), mannitol (41 mg), metacresol (3Â mg) (as a preservative), monobasic sodium phosphate (0.28 mg) and water for injection. The reconstituted concentration is 5 mg/mL with a deliverable volume of 1 mL.</paragraph>
                  <paragraph>GENOTROPIN 12 mg is a singleâpatientâuse, two-chamber cartridge. GENOTROPIN 12 mg is designed for use with a reusable device (GENOTROPIN PEN 12) for product reconstitution and drug delivery. After reconstitution, each mL contains 12Â mg of somatropin, dibasic sodium phosphate (0.4 mg), glycine (2 mg), mannitol (40 mg), metacresol (3 mg) (as a preservative), monobasic sodium phosphate (0.41 mg) and water for injection. The reconstituted concentration is 12 mg/mL with a deliverable volume of 1 mL.</paragraph>
                  <paragraph>GENOTROPIN MINIQUICK is a single-dose Growth Hormone Delivery Device containing a two-chamber cartridge supplied in the following strengths: 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8Â mg, or 2 mg. After reconstitution, each 0.25 mL contains 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2Â mg, 1.4Â mg, 1.6 mg, 1.8 mg, or 2 mg of somatropin, dibasic sodium phosphate (0.03 mg), glycine (0.21Â mg), mannitol (12.5 mg), monobasic sodium phosphate (0.05 mg) and water for injection. Each cartridge provides a deliverable volume of 0.25 mL.</paragraph>
                  <paragraph>The reconstituted recombinant somatropin solution has an osmolality of approximately 300 mOsm/kg, and a pH of approximately 6.7.</paragraph>
               </text>
               <effectiveTime value="20240823"/>
            </section>
         </component>
         <component>
            <section ID="S12">
               <id root="f8337849-a9ff-44be-8334-414e9fbbdcc0"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12	CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20240823"/>
               <component>
                  <section ID="S12.1">
                     <id root="44366c23-a327-4d1d-96e9-92b4b5970517"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1	Mechanism of Action </title>
                     <text>
                        <paragraph>In vitro, preclinical, and clinical tests have demonstrated that GENOTROPIN lyophilized powder is therapeutically equivalent to human growth hormone of pituitary origin and achieves similar pharmacokinetic profiles in normal adults. In pediatric patients who have growth hormone deficiency (GHD), have Prader-Willi syndrome (PWS), were born small for gestational age (SGA), have Turner syndrome (TS), or have Idiopathic short stature (ISS), treatment with GENOTROPIN stimulates linear growth. In patients with GHD or PWS, treatment with GENOTROPIN also normalizes concentrations of IGF-I (Insulin-like Growth Factor-I/Somatomedin C). In adults with GHD, treatment with GENOTROPIN results in reduced fat mass, increased lean body mass, metabolic alterations that include beneficial changes in lipid metabolism, and normalization of IGF-I concentrations.</paragraph>
                        <paragraph>In addition, the following actions have been demonstrated for GENOTROPIN and/or somatropin.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="S12.2">
                     <id root="70a0c507-d3dd-412e-9dfb-a7a7cdebd31b"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2	Pharmacodynamics </title>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_a7cb4cfd-11c0-40c2-9c94-ddcfb0edeba7">
                           <id root="22035dfc-b913-403e-850f-c5e85339ae87"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Tissue Growth</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20240823"/>
                           <component>
                              <section ID="ID_abdc095a-9e65-485b-aa3d-cf6a9e484dc9">
                                 <id root="3464edd4-2c8d-4585-a3c5-8387ca0a7497"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <list listType="ordered">
                                       <item>
                                          <caption>A.</caption>
                                          <content styleCode="bold">
                                             <content styleCode="italics">Skeletal Growth:</content>
                                          </content> GENOTROPIN stimulates skeletal growth in pediatric patients with GHD, PWS, SGA, TS, or ISS. The measurable increase in body length after administration of GENOTROPIN results from an effect on the epiphyseal plates of long bones. Concentrations of IGF-I, which may play a role in skeletal growth, are generally low in the serum of pediatric patients with GHD, PWS, or SGA, but tend to increase during treatment with GENOTROPIN. Elevations in mean serum alkaline phosphatase concentration are also seen.</item>
                                       <item>
                                          <caption>B.</caption>
                                          <content styleCode="bold">
                                             <content styleCode="italics">Cell Growth:</content>
                                          </content> It has been shown that there are fewer skeletal muscle cells in short-statured pediatric patients who lack endogenous growth hormone as compared with the normal pediatric population. Treatment with somatropin results in an increase in both the number and size of muscle cells.</item>
                                    </list>
                                 </text>
                                 <effectiveTime value="20240823"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_7a5ad0af-f70e-42ad-8f96-d2d386005bd4">
                           <id root="5ec733b8-f3b4-47be-84da-4135dcfe93e6"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Protein Metabolism</content>
                              </paragraph>
                              <paragraph>Linear growth is facilitated in part by increased cellular protein synthesis. Nitrogen retention, as demonstrated by decreased urinary nitrogen excretion and serum urea nitrogen, follows the initiation of therapy with GENOTROPIN.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_bf56e0a5-8d98-4270-a695-a608b88cef38">
                           <id root="71b3a4d0-3d61-4b5d-83ab-6e8985770da6"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Carbohydrate Metabolism</content>
                              </paragraph>
                              <paragraph>Pediatric patients with hypopituitarism sometimes experience fasting hypoglycemia that is improved by treatment with GENOTROPIN. Large doses of growth hormone may impair glucose tolerance.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_a1ef7bb2-48e0-47da-b9b9-3c64ba3326b9">
                           <id root="35d66d0b-9094-43d6-92dc-59d95fa36d33"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Lipid Metabolism</content>
                              </paragraph>
                              <paragraph>In GHD patients, administration of somatropin has resulted in lipid mobilization, reduction in body fat stores, and increased plasma fatty acids.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_4b46303d-661e-4fae-9036-7dcaae050f53">
                           <id root="2fef2afc-1544-45bf-97a3-510f231f7fe6"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Mineral Metabolism</content>
                              </paragraph>
                              <paragraph>Somatropin induces retention of sodium, potassium, and phosphorus. Serum concentrations of inorganic phosphate are increased in patients with GHD after therapy with GENOTROPIN. Serum calcium is not significantly altered by GENOTROPIN. Growth hormone could increase calciuria.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_d2717a3e-bb5e-4a4c-b62e-03347c360c22">
                           <id root="f9882848-8b7d-4200-9b41-e7e9fe9a0749"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Body Composition</content>
                              </paragraph>
                              <paragraph>Adult GHD patients treated with GENOTROPIN at the recommended adult dose<content styleCode="italics"> [see </content>
                                 <content styleCode="italics">
                                    <linkHtml href="#S2">Dosage and Administration (2)</linkHtml>
                                 </content>
                                 <content styleCode="italics">] </content>demonstrate a decrease in fat mass and an increase in lean body mass. When these alterations are coupled with the increase in total body water, the overall effect of GENOTROPIN is to modify body composition, an effect that is maintained with continued treatment.</paragraph>
                           </text>
                           <effectiveTime value="20240823"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S12.3">
                     <id root="a3ff6f71-cb73-4f44-abcb-4abc3104b5d0"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3	Pharmacokinetics</title>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_5f4b7fb3-1a51-4010-a704-48e5342a655a">
                           <id root="4943fd27-212e-452b-a50f-4833bf82749c"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Absorption</content>
                              </paragraph>
                              <paragraph>Following a 0.03 mg/kg subcutaneous (SC) injection in the thigh of 1.3 mg/mL GENOTROPIN to adult GHD patients, approximately 80% of the dose was systemically available as compared with that available following intravenous dosing. Results were comparable in both male and female patients. Similar bioavailability has been observed in healthy adult male subjects.</paragraph>
                              <paragraph>In healthy adult males, following an SC injection in the thigh of 0.03 mg/kg, the extent of absorption (AUC) of a concentration of 5.3 mg/mL GENOTROPIN was 35% greater than that for 1.3 mg/mL GENOTROPIN. The mean (Â± standard deviation) peak (C<sub>max</sub>) serum levels were 23.0 (Â± 9.4) ng/mL and 17.4 (Â± 9.2) ng/mL, respectively.</paragraph>
                              <paragraph>In a similar study involving pediatric GHD patients, 5.3 mg/mL GENOTROPIN yielded a mean AUC that was 17% greater than that for 1.3 mg/mL GENOTROPIN. The mean C<sub>max</sub> levels were 21.0 ng/mL and 16.3 ng/mL, respectively.</paragraph>
                              <paragraph>Adult GHD patients received two single SC doses of 0.03 mg/kg of GENOTROPIN at a concentration of 1.3 mg/mL, with a one- to four-week washout period between injections. Mean C<sub>max</sub> levels were 12.4 ng/mL (first injection) and 12.2 ng/mL (second injection), achieved at approximately six hours after dosing.</paragraph>
                              <paragraph>There are no data on the bioequivalence between the 12 mg/mL formulation and either the 1.3 mg/mL or the 5.3 mg/mL formulations.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_f4878ede-d0ee-4e87-9e20-3391090d1bc8">
                           <id root="b2853eef-a2b7-424a-9e06-1a8d19852129"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Distribution</content>
                              </paragraph>
                              <paragraph>The mean volume of distribution of GENOTROPIN following administration to GHD adults was estimated to be 1.3 (Â± 0.8) L/kg.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_9feb1e47-3954-4aac-80ca-bc319a2e1d8a">
                           <id root="b61e8fef-52e1-4922-b305-f16a73408386"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Metabolism</content>
                              </paragraph>
                              <paragraph>The metabolic fate of GENOTROPIN involves classical protein catabolism in both the liver and kidneys. In renal cells, at least a portion of the breakdown products are returned to the systemic circulation. The mean terminal half-life of intravenous GENOTROPIN in normal adults is 0.4 hours, whereas subcutaneously administered GENOTROPIN has a half-life of 3.0 hours in GHD adults. The observed difference is due to slow absorption from the subcutaneous injection site.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_9a4186dc-82d4-43a4-985c-b48ea0705bf7">
                           <id root="3f4cfc24-e194-4fad-8587-4283b9bf32e6"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Excretion</content>
                              </paragraph>
                              <paragraph>The mean clearance of subcutaneously administered GENOTROPIN in 16 GHD adult patients was 0.3 (Â± 0.11) L/hrs/kg.</paragraph>
                           </text>
                           <effectiveTime value="20190401"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_70f67df9-9fd1-4f3c-8f0a-b2aafbffe6f1">
                           <id root="c74bdba1-6d93-430b-830c-0ba4af4f29db"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Special Populations</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20240823"/>
                           <component>
                              <section ID="ID_d98e5aa8-35df-4c78-acf6-34dbec230320">
                                 <id root="5b057400-8f15-40dc-9a19-d8fe70d35953"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="bold">
                                          <content styleCode="italics">Pediatric:</content>
                                       </content> The pharmacokinetics of GENOTROPIN are similar in GHD pediatric and adult patients.</paragraph>
                                 </text>
                                 <effectiveTime value="20190401"/>
                              </section>
                           </component>
                           <component>
                              <section ID="ID_1049aa99-9341-4554-8541-2cc04de15410">
                                 <id root="3d491aef-6a5d-4f54-909f-4d649e96139c"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="bold">
                                          <content styleCode="italics">Gender:</content>
                                       </content> No gender studies have been performed in pediatric patients; however, in GHD adults, the absolute bioavailability of GENOTROPIN was similar in males and females.</paragraph>
                                 </text>
                                 <effectiveTime value="20190401"/>
                              </section>
                           </component>
                           <component>
                              <section ID="ID_52b9323d-abca-41d8-a4f8-062b8817c5ac">
                                 <id root="e62662fe-d12e-4d31-bac8-0a662ea21ac8"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="bold">
                                          <content styleCode="italics">Race:</content>
                                       </content> No studies have been conducted with GENOTROPIN to assess pharmacokinetic differences among races.</paragraph>
                                 </text>
                                 <effectiveTime value="20190401"/>
                              </section>
                           </component>
                           <component>
                              <section ID="ID_ca031f7d-e321-40f2-b4c2-3f785b15e6a3">
                                 <id root="9df16930-3bd5-4a07-916c-71d30ffd0348"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="bold">
                                          <content styleCode="italics">Renal or hepatic insufficiency:</content>
                                       </content> No studies have been conducted with GENOTROPIN in these patient populations.</paragraph>
                                    <table ID="_Reftable2" width="100%">
                                       <caption>Table 2. Mean SC Pharmacokinetic Parameters in Adult GHD Patients</caption>
                                       <col width="16%"/>
                                       <col width="17%"/>
                                       <col width="17%"/>
                                       <col width="17%"/>
                                       <col width="17%"/>
                                       <col width="16%"/>
                                       <thead>
                                          <tr>
                                             <th align="left" styleCode="Rrule Botrule Toprule " valign="top"/>
                                             <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <content styleCode="bold">Bioavailability</content>
                                                <br/>
                                                <content styleCode="bold">(%)</content>
                                                <br/>
                                                <content styleCode="bold">(N=15)</content>
                                             </th>
                                             <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <content styleCode="bold">T<sub>max</sub>
                                                </content>
                                                <br/>
                                                <content styleCode="bold">(hours)</content>
                                                <br/>
                                                <content styleCode="bold">(N=16)</content>
                                             </th>
                                             <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <content styleCode="bold">CL/F</content>
                                                <br/>
                                                <content styleCode="bold">(L/hr Ã kg)</content>
                                                <br/>
                                                <content styleCode="bold">(N=16)</content>
                                             </th>
                                             <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <content styleCode="bold">Vss/F</content>
                                                <br/>
                                                <content styleCode="bold">(L/kg)</content>
                                                <br/>
                                                <content styleCode="bold">(N=16)</content>
                                             </th>
                                             <th align="center" styleCode="Botrule Toprule " valign="top">
                                                <content styleCode="bold">T<sub>1/2</sub>
                                                </content>
                                                <br/>
                                                <content styleCode="bold">(hours)</content>
                                                <br/>
                                                <content styleCode="bold">(N=16)</content>
                                             </th>
                                          </tr>
                                       </thead>
                                       <tfoot>
                                          <tr>
                                             <td align="left" colspan="6" valign="top">T<sub>max</sub> = time of maximum plasma concentration<br/>CL/F = plasma clearance<br/>Vss/F = volume of distribution</td>
                                          </tr>
                                          <tr>
                                             <td align="left" colspan="6" valign="top">T <sub>1/2</sub> = terminal half-life<br/>SD = standard deviation<br/>CI = confidence interval</td>
                                          </tr>
                                       </tfoot>
                                       <tbody>
                                          <tr>
                                             <td align="center" styleCode="Rrule Toprule " valign="top">
                                                <paragraph>Mean</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Toprule " valign="top">
                                                <paragraph>80.5</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Toprule " valign="top">
                                                <paragraph>5.9</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Toprule " valign="top">
                                                <paragraph>0.3</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Toprule " valign="top">
                                                <paragraph>1.3</paragraph>
                                             </td>
                                             <td align="center" styleCode="Toprule " valign="top">
                                                <paragraph>3.0</paragraph>
                                             </td>
                                          </tr>
                                          <tr>
                                             <td align="center" styleCode="Rrule " valign="top">
                                                <paragraph>(Â± SD)</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule " valign="top">
                                                <paragraph>
                                                   <footnote ID="_RefID0EYCCI">The absolute bioavailability was estimated under the assumption that the log-transformed data follow a normal distribution. The mean and standard deviation of the log-transformed data were mean = 0.22 (Â± 0.241).</footnote>
                                                </paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule " valign="top">
                                                <paragraph>(Â± 1.65)</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule " valign="top">
                                                <paragraph>(Â± 0.11)</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule " valign="top">
                                                <paragraph>(Â± 0.80)</paragraph>
                                             </td>
                                             <td align="center" valign="top">
                                                <paragraph>(Â± 1.44)</paragraph>
                                             </td>
                                          </tr>
                                          <tr>
                                             <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <paragraph>95% CI</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <paragraph>70.5 â 92.1</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <paragraph>5.0 â 6.7</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <paragraph>0.2 â 0.4</paragraph>
                                             </td>
                                             <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                                <paragraph>0.9 â 1.8</paragraph>
                                             </td>
                                             <td align="center" styleCode="Botrule Toprule " valign="top">
                                                <paragraph>2.2 â 3.7</paragraph>
                                             </td>
                                          </tr>
                                       </tbody>
                                    </table>
                                 </text>
                                 <effectiveTime value="20240823"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="ID_494aaada-52a9-4b9a-b9c3-26271d19de7a">
                     <id root="33610fed-5e77-4954-af94-7d9771a855f8"/>
                     <code code="88830-5" codeSystem="2.16.840.1.113883.6.1" displayName="IMMUNOGENICITY"/>
                     <title>12.6	Immunogenicity </title>
                     <text>
                        <paragraph>The observed incidence of anti-drug antibodies is highly dependent on the sensitivity and specificity of the assay. Differences in assay methods preclude meaningful comparisons of the incidence of anti-drug antibodies in the studies described below with the incidence of anti-drug antibodies in other studies, including those of GENOTROPIN or other somatropins.</paragraph>
                        <paragraph>In the case of growth hormone, antibodies with binding capacities lower than 2 mg/mL have not been associated with growth attenuation. In a very small number of patients treated with somatropin, when binding capacity was greater than 2 mg/mL, interference with the growth response was observed.</paragraph>
                        <paragraph>In 419 pediatric patients evaluated in clinical studies with GENOTROPIN lyophilized powder, 244 had been treated previously with GENOTROPIN or other growth hormone preparations and 175 had received no previous growth hormone therapy. Antibodies to growth hormone (anti-hGH antibodies) were present in six previously treated patients at baseline. Three of the six became negative for anti-hGH antibodies during 6 to 12Â months of treatment with GENOTROPIN. Of the remaining 413Â patients, eight (1.9%) developed detectable anti-hGH antibodies during treatment with GENOTROPIN; none had an antibody binding capacity &gt;2 mg/L. There was no evidence that the growth response to GENOTROPIN was affected in these antibody-positive patients.</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S13">
               <id root="e41d1e89-f0a5-47a9-973d-5aab71c6efce"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13	NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20240823"/>
               <component>
                  <section ID="S13.1">
                     <id root="d277d2ae-84e5-416d-827e-b1d9b64e0969"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1	Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Carcinogenicity studies have not been conducted with GENOTROPIN. No potential mutagenicity of GENOTROPIN was revealed in a battery of tests including induction of gene mutations in bacteria (the Ames test), gene mutations in mammalian cells grown in vitro (mouse L5178Y cells), and chromosomal damage in intact animals (bone marrow cells in rats). </paragraph>
                        <paragraph>In a fertility study in male and female rats receiving SC doses during gametogenesis (2 weeks prior to mating for females and 9 weeks prior to mating for males) and continuing up to 7 days of pregnancy, 3.3Â mg/kg/day (approximately 24 times human dose by body surface area) produced anestrus or extended estrus cycles in females and fewer and less motile sperm in males. Lower copulation and pregnancy rates were also observed at 3.3 mg/kg/day. At 1 mg/kg/day (approximately 7 times human dose by body surface area), rats showed slightly extended estrus cycles, whereas at 0.3Â mg/kg/day no effects were noted (approximately 2 times human dose by body surface).</paragraph>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S14">
               <id root="81063caa-642a-4b4d-9679-08f80dfc1f3d"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14	CLINICAL STUDIES </title>
               <effectiveTime value="20240823"/>
               <component>
                  <section ID="ID_6d9bfdbe-8be7-4884-bd8b-8b4bb58acfcd">
                     <id root="4c3b7995-48d3-40c4-afd0-2c2fa34e0028"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1	Adult Growth Hormone Deficiency (GHD)</title>
                     <text>
                        <paragraph>GENOTROPIN lyophilized powder was compared with placebo in six randomized clinical trials involving a total of 172 adult GHD patients. These trials included a 6-month double-blind treatment period, during which 85 patients received GENOTROPIN and 87 patients received placebo, followed by an open-label treatment period in which participating patients received GENOTROPIN for up to a total of 24 months. GENOTROPIN was administered as a daily SC injection at a dose of 0.04 mg/kg/week for the first month of treatment and 0.08 mg/kg/week for subsequent months.</paragraph>
                        <paragraph>Beneficial changes in body composition were observed at the end of the 6-month treatment period for the patients receiving GENOTROPIN as compared with the placebo patients. Lean body mass, total body water, and lean/fat ratio increased while total body fat mass and waist circumference decreased. These effects on body composition were maintained when treatment was continued beyond 6 months. Bone mineral density declined after 6 months of treatment but returned to baseline values after 12 months of treatment.</paragraph>
                     </text>
                     <effectiveTime value="20190401"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6e0def5e-a0ae-4889-ad76-e100379045cb">
                     <id root="ff1ae780-82ba-466c-8fca-bc0c88fa4933"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2	Prader-Willi Syndrome (PWS)</title>
                     <text>
                        <paragraph>The safety and efficacy of GENOTROPIN in the treatment of pediatric patients with Prader-Willi syndrome (PWS) were evaluated in two randomized, open-label, controlled clinical trials. Patients received either GENOTROPIN or no treatment for the first year of the studies, while all patients received GENOTROPIN during the second year. GENOTROPIN was administered as a daily SC injection, and the dose was calculated for each patient every 3 months. In Study 1, the treatment group received GENOTROPIN at a dose of 0.24 mg/kg/week during the entire study. During the second year, the control group received GENOTROPIN at a dose of 0.48 mg/kg/week. In Study 2, the treatment group received GENOTROPIN at a dose of 0.36 mg/kg/week during the entire study. During the second year, the control group received GENOTROPIN at a dose of 0.36 mg/kg/week.</paragraph>
                        <paragraph>Patients who received GENOTROPIN showed significant increases in linear growth during the first year of study, compared with patients who received no treatment (see <linkHtml href="#_Reftable3">Table 3</linkHtml>). Linear growth continued to increase in the second year, when both groups received treatment with GENOTROPIN.</paragraph>
                        <table ID="_Reftable3" width="100%">
                           <caption>Table 3. Efficacy of GENOTROPIN in Pediatric Patients with Prader-Willi Syndrome (Mean Â± SD)</caption>
                           <col width="23%"/>
                           <col width="23%"/>
                           <col width="18%"/>
                           <col width="18%"/>
                           <col width="18%"/>
                           <thead>
                              <tr>
                                 <th align="left" rowspan="3" styleCode="Botrule Toprule " valign="top"/>
                                 <th align="left" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Study 1</content>
                                 </th>
                                 <th align="left" colspan="2" styleCode="Botrule Toprule " valign="top">
                                    <content styleCode="bold">Study 2</content>
                                 </th>
                              </tr>
                              <tr>
                                 <th align="left" styleCode="Rrule Lrule " valign="top">
                                    <content styleCode="bold">
                                       <content styleCode="underline">GENOTROPIN</content>
                                    </content>
                                 </th>
                                 <th align="center" rowspan="2" styleCode="Rrule " valign="top">
                                    <content styleCode="bold">Untreated Control</content>
                                    <br/>
                                    <content styleCode="bold">n=12</content>
                                 </th>
                                 <th align="left" styleCode="Rrule " valign="top">
                                    <content styleCode="bold">
                                       <content styleCode="underline">GENOTROPIN</content>
                                    </content>
                                 </th>
                                 <th align="center" rowspan="2" valign="top">
                                    <content styleCode="bold">Untreated Control</content>
                                    <br/>
                                    <content styleCode="bold">n=9</content>
                                 </th>
                              </tr>
                              <tr>
                                 <th align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <content styleCode="bold">(0.24 mg/kg/week)</content>
                                    <br/>
                                    <content styleCode="bold">n=15</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule " valign="top">
                                    <content styleCode="bold">(0.36 mg/kg/week)</content>
                                    <br/>
                                    <content styleCode="bold">n=7</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Linear growth (cm)</content>
                                       <br/>Â Â Baseline height</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="bottom">
                                    <paragraph>112.7 Â± 14.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="bottom">
                                    <paragraph>109.5 Â± 12.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="bottom">
                                    <paragraph>120.3 Â± 17.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule Botrule " valign="bottom">
                                    <paragraph>120.5 Â± 11.2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â Growth from months 0 to 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>11.6<footnote ID="_Refft2">p â¤ 0.001</footnote> Â± 2.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>5.0 Â± 1.2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>10.7<footnoteRef IDREF="_Refft2"/> Â± 2.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>4.3 Â± 1.5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height Standard Deviation Score (SDS) for age</content>
                                       <br/>Â Â Baseline SDS</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>-1.6 Â± 1.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>-1.8 Â± 1.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>-2.6 Â± 1.7</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="bottom">
                                    <paragraph>-2.1 Â± 1.4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â SDS at 12 months</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>-0.5<footnote ID="_Refft3">p â¤ 0.002 (when comparing SDS change at 12 months)</footnote> Â± 1.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>-1.9 Â± 1.4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>-1.4<footnoteRef IDREF="_Refft3"/> Â± 1.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>-2.2 Â± 1.4</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Changes in body composition were also observed in the patients receiving GENOTROPIN (see <linkHtml href="#_Reftable4">Table 4</linkHtml>). These changes included a decrease in the amount of fat mass, and increases in the amount of lean body mass and the ratio of lean-to-fat tissue, while changes in body weight were similar to those seen in patients who received no treatment. Treatment with GENOTROPIN did not accelerate bone age, compared with patients who received no treatment.</paragraph>
                        <table ID="_Reftable4" width="100%">
                           <caption>Table 4. Effect of GENOTROPIN on Body Composition in Pediatric Patients with Prader-Willi Syndrome (Mean Â± SD)</caption>
                           <col width="33%"/>
                           <col width="33%"/>
                           <col width="34%"/>
                           <thead>
                              <tr>
                                 <th align="left" rowspan="2" styleCode="Rrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Toprule " valign="top">
                                    <content styleCode="bold">
                                       <content styleCode="underline">GENOTROPIN</content>
                                    </content>
                                 </th>
                                 <th align="center" rowspan="2" styleCode="Toprule " valign="top">
                                    <content styleCode="bold">Untreated Control</content>
                                    <br/>
                                    <content styleCode="bold">n=10</content>
                                 </th>
                              </tr>
                              <tr>
                                 <th align="center" styleCode="Rrule Botrule " valign="top">
                                    <content styleCode="bold">n=14</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fat mass (kg)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Toprule " valign="top"/>
                                 <td styleCode="Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>12.3 Â± 6.8</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>9.4 Â± 4.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change from months 0 to 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>-0.9<footnote ID="_Refft4">p &lt; 0.005</footnote> Â± 2.2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule Botrule " valign="top">
                                    <paragraph>2.3 Â± 2.4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Lean body mass (kg)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule " valign="top"/>
                                 <td valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>15.6 Â± 5.7</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>14.3 Â± 4.0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change from months 0 to 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>4.7<footnoteRef IDREF="_Refft4"/> Â± 1.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule Botrule " valign="top">
                                    <paragraph>0.7 Â± 2.4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Lean body mass/Fat mass</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Toprule " valign="top"/>
                                 <td styleCode="Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>1.4 Â± 0.4</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>1.8 Â± 0.8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change from months 0 to 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>1.0<footnoteRef IDREF="_Refft4"/> Â± 1.4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule Botrule " valign="top">
                                    <paragraph>-0.1 Â± 0.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body weight (kg) </content>
                                       <footnote ID="_RefID0EIOCI">n=15 for the group receiving GENOTROPIN; n=12 for the Control group</footnote>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule " valign="top"/>
                                 <td valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>27.2 Â± 12.0</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>23.2 Â± 7.0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Â Â Change from months 0 to 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>3.7<footnote ID="_RefID0EYOCI">n.s.</footnote> Â± 2.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Toprule " valign="top">
                                    <paragraph>3.5 Â± 1.9</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6cb41885-b3a2-4b0e-9035-621d29e90cc7">
                     <id root="47d3bd7a-57b2-4ae2-a2ee-bcce9c6c88b4"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.3	Small for Gestational Age</title>
                     <effectiveTime value="20240823"/>
                     <component>
                        <section ID="ID_8301ba7a-7172-490b-8a8a-b5910aa234fd">
                           <id root="aa7f3145-599c-413b-8d25-bb1465c85b0d"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="bold">Pediatric Patients Born Small for Gestational Age (SGA) Who Fail to Manifest Catch-up Growth by Age 2</content>
                              </paragraph>
                              <paragraph>The safety and efficacy of GENOTROPIN in the treatment of pediatric patients born small for gestational age (SGA) were evaluated in 4 randomized, open-label, controlled clinical trials. Patients (age range of 2 to 8 years) were observed for 12 months before being randomized to receive either GENOTROPIN (two doses per study, most often 0.24 and 0.48 mg/kg/week) as a daily SC injection or no treatment for the first 24 months of the studies. After 24 months in the studies, all patients received GENOTROPIN.</paragraph>
                              <paragraph>Patients who received any dose of GENOTROPIN showed significant increases in growth during the first 24 months of study, compared with patients who received no treatment (see <linkHtml href="#_Reftable5">Table 5</linkHtml>). Children receiving 0.48 mg/kg/week demonstrated a significant improvement in height standard deviation score (SDS) compared with children treated with 0.24 mg/kg/week. Both of these doses resulted in a slower but constant increase in growth between months 24 to 72 (data not shown).</paragraph>
                              <table ID="_Reftable5" width="100%">
                                 <caption>Table 5. Efficacy of GENOTROPIN in Pediatric Patients Born Small for Gestational Age (Mean Â± SD)</caption>
                                 <col width="27%"/>
                                 <col width="27%"/>
                                 <col width="23%"/>
                                 <col width="23%"/>
                                 <thead>
                                    <tr>
                                       <th align="left" rowspan="2" styleCode="Rrule Toprule " valign="top"/>
                                       <th align="center" styleCode="Rrule Toprule " valign="top">
                                          <content styleCode="bold">
                                             <content styleCode="underline">GENOTROPIN</content>
                                          </content>
                                       </th>
                                       <th align="center" styleCode="Rrule Toprule " valign="top">
                                          <content styleCode="bold">
                                             <content styleCode="underline">GENOTROPIN</content>
                                          </content>
                                       </th>
                                       <th align="center" rowspan="2" styleCode="Toprule " valign="top">
                                          <content styleCode="bold">Untreated Control</content>
                                          <br/>
                                          <content styleCode="bold">n=40</content>
                                       </th>
                                    </tr>
                                    <tr>
                                       <th align="center" styleCode="Rrule Botrule " valign="top">
                                          <content styleCode="bold">(0.24 mg/kg/week)</content>
                                          <br/>
                                          <content styleCode="bold">n=76</content>
                                       </th>
                                       <th align="center" styleCode="Rrule Botrule " valign="top">
                                          <content styleCode="bold">(0.48 mg/kg/week)</content>
                                          <br/>
                                          <content styleCode="bold">n=93</content>
                                       </th>
                                    </tr>
                                 </thead>
                                 <tbody>
                                    <tr>
                                       <td styleCode="Rrule Toprule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Height Standard Deviation Score (SDS)</content>
                                          </paragraph>
                                       </td>
                                       <td styleCode="Rrule Toprule " valign="top"/>
                                       <td styleCode="Rrule Toprule " valign="top"/>
                                       <td styleCode="Toprule " valign="top"/>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule " valign="top">
                                          <paragraph>Baseline SDS</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>-3.2 Â± 0.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule " valign="top">
                                          <paragraph>-3.4 Â± 1.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Botrule " valign="top">
                                          <paragraph>-3.1 Â± 0.9</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Toprule Botrule " valign="top">
                                          <paragraph>SDS at 24 months</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                          <paragraph>-2.0 Â± 0.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                          <paragraph>-1.7 Â± 1.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Botrule " valign="top">
                                          <paragraph>-2.9 Â± 0.9</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Botrule " valign="top">
                                          <paragraph>Change in SDS from baseline to month 24</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>1.2<footnote ID="_Refft5">p = 0.0001 vs Untreated Control group</footnote> Â± 0.5</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule " valign="top">
                                          <paragraph>1.7<footnoteRef IDREF="_Refft5"/>
                                             <footnote ID="_RefID0E3SCI">p = 0.0001 vs group treated with GENOTROPIN 0.24 mg/kg/week</footnote> Â± 0.6</paragraph>
                                       </td>
                                       <td align="center" styleCode="Botrule " valign="top">
                                          <paragraph>0.1 Â± 0.3</paragraph>
                                       </td>
                                    </tr>
                                 </tbody>
                              </table>
                           </text>
                           <effectiveTime value="20240823"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="ID_1ad9e8dc-5dfb-40f7-bccf-5d7392fbf260">
                     <id root="31bb2271-31a2-4ddb-af3d-d80d5ff155c0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.4	Turner Syndrome</title>
                     <text>
                        <paragraph>Two randomized, open-label, clinical trials were conducted that evaluated the efficacy and safety of GENOTROPIN in Turner syndrome patients with short stature. Turner syndrome patients were treated with GENOTROPIN alone or GENOTROPIN plus adjunctive hormonal therapy (ethinylestradiol or oxandrolone). A total of 38 patients were treated with GENOTROPIN alone in the two studies. In Study 055, 22 patients were treated for 12 months, and in Study 092, 16 patients were treated for 12 months. Patients received GENOTROPIN at a dose between 0.13 to 0.33 mg/kg/week.</paragraph>
                        <paragraph>SDS for height velocity and height are expressed using either the Tanner (Study 055) or SempÃ© (Study 092) standards for age-matched normal children as well as the Ranke standard (both studies) for age-matched, untreated Turner syndrome patients. As seen in Table 6, height velocity SDS and height SDS values were smaller at baseline and after treatment with GENOTROPIN when the normative standards were utilized as opposed to the Turner syndrome standard.</paragraph>
                        <paragraph>Both studies demonstrated statistically significant increases from baseline in all of the linear growth variables (i.e., mean height velocity, height velocity SDS, and height SDS) after treatment with GENOTROPIN (see <linkHtml href="#_Reftable6">Table 6</linkHtml>). The linear growth response was greater in Study 055 wherein patients were treated with a larger dose of GENOTROPIN.</paragraph>
                        <table ID="_Reftable6" width="100%">
                           <caption>Table 6. Growth Parameters (mean Â± SD) after 12 Months of Treatment with GENOTROPIN in Pediatric Patients with Turner Syndrome in Two Open Label Studies</caption>
                           <col width="36%"/>
                           <col width="32%"/>
                           <col width="32%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">
                                       <content styleCode="underline">GENOTROPIN</content>
                                    </content>
                                    <br/>
                                    <content styleCode="bold">0.33 mg/kg/week</content>
                                    <br/>
                                    <content styleCode="bold">Study 055^ n=22</content>
                                 </th>
                                 <th align="center" styleCode="Botrule Toprule " valign="top">
                                    <content styleCode="bold">
                                       <content styleCode="underline">GENOTROPIN </content>
                                    </content>
                                    <br/>
                                    <content styleCode="bold">0.13â0.23 mg/kg/week</content>
                                    <br/>
                                    <content styleCode="bold">Study 092# n=16</content>
                                 </th>
                              </tr>
                           </thead>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="3" valign="top">SDS = Standard Deviation Score<br/> Ranke standard based on age-matched, untreated Turner syndrome patients<br/> Tanner^/SempÃ©# standards based on age-matched normal children<br/> p&lt;0.05, for all changes from baseline</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height Velocity (cm/yr)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Toprule " valign="top"/>
                                 <td styleCode="Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>4.1 Â± 1.5</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>3.9 Â± 1.0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Month 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>7.8 Â± 1.6</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>6.1 Â± 0.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â Change from baseline (95% CI)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>3.7 (3.0, 4.3)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>2.2 (1.5, 2.9)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height Velocity SDS (Tanner^/SempÃ©# Standards)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>(n=20)</paragraph>
                                 </td>
                                 <td valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>-2.3 Â± 1.4</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>-1.6 Â± 0.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Month 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>2.2 Â± 2.3</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>0.7 Â± 1.3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Change from baseline (95% CI)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>4.6 (3.5, 5.6)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>2.2 (1.4, 3.0)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height Velocity SDS (Ranke Standard)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Toprule " valign="top"/>
                                 <td styleCode="Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>-0.1 Â± 1.2</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>-0.4 Â± 0.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Month 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>4.2 Â± 1.2</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>2.3 Â± 1.2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â Change from baseline (95% CI)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>4.3 (3.5, 5.0)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>2.7 (1.8, 3.5)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height SDS (Tanner^/SempÃ©# Standards)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule " valign="top"/>
                                 <td valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>-3.1 Â± 1.0</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>-3.2 Â± 1.0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Month 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>-2.7 Â± 1.1</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>-2.9 Â± 1.0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â Change from baseline (95% CI)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>0.4 (0.3, 0.6)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>0.3 (0.1, 0.4)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Height SDS (Ranke Standard)</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule " valign="top"/>
                                 <td valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>-0.2 Â± 0.8</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>-0.3 Â± 0.8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>Â Â Month 12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>0.6 Â± 0.9</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>0.1 Â± 0.8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Â Â Change from baseline (95% CI)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>0.8 (0.7, 0.9)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>0.5 (0.4, 0.5)</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_b5e881d3-c8b2-4d30-8832-800030522437">
                     <id root="151c3911-bcd8-4eff-b01e-f79431536c5a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.5	Idiopathic Short Stature</title>
                     <text>
                        <paragraph>The long-term efficacy and safety of GENOTROPIN in patients with idiopathic short stature (ISS) were evaluated in one randomized, open-label, clinical trial that enrolled 177 children. Patients were enrolled on the basis of short stature, stimulated GH secretion &gt;10 ng/mL, and prepubertal status (criteria for idiopathic short stature were retrospectively applied and included 126 patients). All patients were observed for height progression for 12 months and were subsequently randomized to GENOTROPIN or observation only and followed to final height. Two GENOTROPIN doses were evaluated in this trial: 0.23 mg/kg/week (0.033 mg/kg/day) and 0.47 mg/kg/week (0.067 mg/kg/day). Baseline patient characteristics for the ISS patients who remained prepubertal at randomization (n= 105) were: mean (Â± SD): chronological age 11.4 (1.3) years, height SDS -2.4 (0.4), height velocity SDS -1.1 (0.8), and height velocity 4.4 (0.9) cm/yr, IGF-1 SDS -0.8 (1.4). Patients were treated for a median duration of 5.7 years. Results for final height SDS are displayed by treatment arm in Table 7. GENOTROPIN therapy improved final height in ISS children relative to untreated controls. The observed mean gain in final height was 9.8 cm for females and 5.0 cm for males for both doses combined compared to untreated control subjects. A height gain of 1 SDS was observed in 10% of untreated subjects, 50% of subjects receiving 0.23 mg/kg/week and 69% of subjects receiving 0.47 mg/kg/week.</paragraph>
                        <table ID="_Reftable7" width="85%">
                           <caption>Table 7. Final height SDS results for pre-pubertal patients with ISS<footnote ID="_RefID0E3ZCI">Mean (SD) are observed values.</footnote>
                           </caption>
                           <col width="23%"/>
                           <col width="15%"/>
                           <col width="14%"/>
                           <col width="14%"/>
                           <col width="15%"/>
                           <col width="15%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">Untreated</content>
                                    <br/>
                                    <content styleCode="bold">(n=30)</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">GEN 0.033</content>
                                    <br/>
                                    <content styleCode="bold">(n=30)</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">GEN 0.067</content>
                                    <br/>
                                    <content styleCode="bold">(n=42)</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">GEN 0.033 vs. Untreated</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">GEN 0.067 vs. Untreated</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </th>
                              </tr>
                           </thead>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="6" valign="top">**Least square means based on ANCOVA (final height SDS and final height SDS minus baseline predicted height SDS were adjusted for baseline height SDS)</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td styleCode="Lrule Toprule " valign="top">
                                    <paragraph>Baseline height SDS</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule " valign="top"/>
                                 <td styleCode="Lrule Toprule " valign="top"/>
                                 <td styleCode="Lrule Toprule " valign="top"/>
                                 <td styleCode="Lrule Toprule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule " valign="top">
                                    <paragraph>Final height SDS minus baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule " valign="top">
                                    <paragraph>0.41 (0.58)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule " valign="top">
                                    <paragraph>0.95 (0.75)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule " valign="top">
                                    <paragraph>1.36 (0.64)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule " valign="top">
                                    <paragraph>+0.53 (0.20, 0.87)<br/>p=0.0022</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule " valign="top">
                                    <paragraph>+0.94 (0.63, 1.26)<br/>p&lt;0.0001</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule " valign="top">
                                    <paragraph>Baseline predicted ht</paragraph>
                                 </td>
                                 <td styleCode="Lrule " valign="top"/>
                                 <td styleCode="Lrule " valign="top"/>
                                 <td styleCode="Lrule " valign="top"/>
                                 <td styleCode="Lrule " valign="top"/>
                                 <td styleCode="Rrule Lrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Botrule Lrule " valign="top">
                                    <paragraph>Final height SDS minus baseline predicted final height SDS</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule " valign="top">
                                    <paragraph>0.23 (0.66)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule " valign="top">
                                    <paragraph>0.73 (0.63)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule " valign="top">
                                    <paragraph>1.05 (0.83)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule " valign="top">
                                    <paragraph>+0.60 (0.09, 1.11)<br/>p=0.0217</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule " valign="top">
                                    <paragraph>+0.90 (0.42, 1.39)<br/>p=0.0004</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S16">
               <id root="7d0bbebf-526f-4020-b916-c1d318e33a9a"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16	HOW SUPPLIED/STORAGE AND HANDLING</title>
               <effectiveTime value="20240823"/>
               <component>
                  <section ID="ID_60c8e7ef-5103-40d0-84da-693776c2e249">
                     <id root="92747338-0272-4014-b73d-f4c4d305753e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>16.1	How Supplied </title>
                     <text>
                        <paragraph>GENOTROPIN (somatropin) for injection is a white, lyophilized powder in a single-patient-use or single-dose, two-chamber cartridge intended for subcutaneous injection after reconstitution. The front chamber contains somatropin and the rear chamber contains the diluent. </paragraph>
                        <paragraph>GENOTROPIN lyophilized powder is available in the following packages:</paragraph>
                        <paragraph>
                           <content styleCode="italics">5 mg singleâpatientâuse two-chamber cartridge (with preservative)</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>After reconstitution the final concentration is 5 mg/mL </item>
                           <item>
                              <caption>â¢</caption>For use with the GENOTROPIN PEN 5 Growth Hormone Delivery Device.</item>
                           <item>
                              <caption>â¢</caption>Package of 1Â Â Â Â NDC 0013-2626-81</item>
                        </list>
                        <paragraph>
                           <content styleCode="italics">12 mg singleâpatientâuse two-chamber cartridge (with preservative)</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>After reconstitution the final concentration is 12 mg/mL</item>
                           <item>
                              <caption>â¢</caption>For use with the GENOTROPIN PEN 12 Growth Hormone Delivery Device.</item>
                           <item>
                              <caption>â¢</caption>Package of 1Â Â Â Â NDC 0013-2646-81</item>
                        </list>
                        <paragraph>
                           <content styleCode="italics">GENOTROPIN MINIQUICK, a single-dose Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>After reconstitution, each GENOTROPIN MINIQUICK delivers 0.25 mL, regardless of strength. </item>
                        </list>
                        <paragraph>GENOTROPIN MINIQUICK is available in the following strengths, each in a package of 7:</paragraph>
                        <table width="100%">
                           <col width="24%"/>
                           <col width="34%"/>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Strength</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">NDC Number</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.2 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2649-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.4 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2650-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.6 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2651-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.8 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2652-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2653-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1.2 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2654-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1.4 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2655-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1.6 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2656-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1.8 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0013-2657-02</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>2 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>NDC 0013-2658-02</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_710ae7cc-d38c-43b0-ae23-ade9e7d0d43a">
                     <id root="a286e0da-b73c-4ee0-80e0-e1f893fd4511"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>16.2	Storage and Handling </title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">The 5 mg and 12 mg GENOTROPIN single-patient-use cartridges:</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Store GENOTROPIN lyophilized powder under refrigeration at 36Â°F to 46Â°F (2Â°C to 8Â°C) until the expiration date. Store in the package to protect from light. Do not freeze.</item>
                           <item>
                              <caption>â¢</caption>After reconstitution, store the pen (with the cartridge) in the pen box with the pen cap on to protect from light. Store under refrigeration at 36Â°F to 46Â°F (2Â°C to 8Â°C) between each use, for up to 28 days. Do not shake. Discard the cartridge and any unused medication after 28 days. Use a GENOTROPIN PEN 5, a medical device, to reconstitute the 5 mg two-chamber cartridge, and use a GENOTROPIN PEN 12 to reconstitute the 12 mg two-chamber cartridge.</item>
                        </list>
                        <paragraph>
                           <content styleCode="italics">The 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg and 2 mg single-dose Growth Hormone Delivery Devices containing a two-chamber cartridge (GENOTROPIN MINIQUICK):</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Store GENOTROPIN MINIQUICK under refrigeration at 36Â°F to 46Â°F (2Â°C to 8Â°C) until the expiration date. If needed, may be stored for up to 3 months at room temperature at or below 77Â°F (25Â°C) prior to reconstitution. Do not freeze.</item>
                           <item>
                              <caption>â¢</caption>After reconstitution, store GENOTROPIN MINIQUICK in the package with the pen cap on to protect from light. If needed, may be stored under refrigeration at 36Â°F to 46Â°F (2Â°C to 8Â°C) for up to 24 hours before use. Do not shake. The GENOTROPIN MINIQUICK should be used only once and then discarded.</item>
                        </list>
                     </text>
                     <effectiveTime value="20240823"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S17">
               <id root="9ebc38d5-242a-4559-b1e7-27928a05c568"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17	PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>Patients being treated with GENOTROPIN (and/or their parents) should be informed about the potential benefits and risks associated with GENOTROPIN treatment. This information is intended to better educate patients (and caregivers); it is not a disclosure of all possible adverse or intended effects.</paragraph>
                  <paragraph>Patients and caregivers who will administer GENOTROPIN should receive appropriate training and instruction on the proper use of GENOTROPIN from the physician or other suitably qualified health care professional. A puncture-resistant container for the disposal of used syringes and needles should be strongly recommended. Patients and/or parents should be thoroughly instructed in the importance of proper disposal, and cautioned against any reuse of needles and syringes. This information is intended to aid in the safe and effective administration of the medication.</paragraph>
                  <paragraph>GENOTROPIN is supplied in a two-chamber cartridge, with the lyophilized powder in the front chamber and a diluent in the rear chamber. A reconstitution device is used to mix the diluent and powder.</paragraph>
                  <paragraph>The GENOTROPIN 5 mg and 12 mg cartridges are color-coded to help ensure proper use with the GENOTROPIN PEN delivery device. The 5 mg cartridge has a green tip to match the green pen window on the Pen 5, while the 12 mg cartridge has a purple tip to match the purple pen window on the Pen 12.</paragraph>
                  <paragraph>Follow the directions for reconstitution provided with each device. Do not shake; shaking may cause denaturation of the active ingredient.</paragraph>
                  <paragraph>Please see accompanying directions for use of the reconstitution and/or delivery device.</paragraph>
               </text>
               <effectiveTime value="20240823"/>
            </section>
         </component>
         <component>
            <section ID="ID_ac5fadfc-7ed7-428c-a4ca-052eaedcb6ac">
               <id root="5c235173-059d-47a1-af71-016392ca2e2d"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>Manufactured by:<br/>Pharmacia &amp; Upjohn Company LLC<br/>A subsidiary of Pfizer Inc.<br/>New York, NY 10001<br/>
                     <br/>U.S. License No. 1216<br/>
                  </paragraph>
                  <paragraph>This productâs labeling may have been updated. For the most recent prescribing information, please visit <linkHtml href="http://www.pfizer.com">www.pfizer.com</linkHtml>.</paragraph>
                  <renderMultiMedia ID="id328641990" referencedObject="ID_2b02c7c6-6713-4e7a-a7bc-402eb5765333"/>
                  <paragraph>LAB-0222-25.0</paragraph>
               </text>
               <effectiveTime value="20240823"/>
               <component>
                  <observationMedia ID="ID_2b02c7c6-6713-4e7a-a7bc-402eb5765333">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_00bc1c94-5608-4f95-b9eb-2b280d0328bf">
               <id root="558eccc1-8cd4-49a9-a836-1f22a1f74df0"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Instructions for Use </title>
               <text>
                  <renderMultiMedia ID="id1226804556" referencedObject="EF5D593F-36C6-4A87-96FC-2F7769CF827E"/>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                     <br/>
                     <content styleCode="bold">GENOTROPIN 5 (JEEN-o-tro-pin 5)</content>
                     <br/>
                     <content styleCode="bold">GENOTROPIN PEN 5 is a medical device used to mix and inject doses of reconstituted GENOTROPIN (somatropin) for injection. Use this device only for administration of GENOTROPIN.</content>
                  </paragraph>
                  <table width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Important Note</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top">
                              <paragraph>Please read these instructions completely before using the GENOTROPIN PEN 5. These instructions need to be followed step by step. Please do not use the GENOTROPIN PEN 5 unless your healthcare provider has trained you.<br/>If there is anything you do not understand or cannot do, call the Pfizer Bridge Program toll-free number at 1-800-645-1280. If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>Your pen should not be used near electrical or electronic equipment, including mobile phones. If your pen has been damaged, it should not be used and should be disposed of as instructed by your healthcare provider.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>GENOTROPIN PEN 5 is a reusable multi-dose device holding a 2-chamber cartridge of GENOTROPIN, used to mix and inject GENOTROPIN during a 2 year use period.</paragraph>
                  <paragraph>
                     <content styleCode="bold">For your injection you will need:</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>1 GENOTROPIN PEN 5 device</item>
                     <item>
                        <caption>â¢</caption>1 GENOTROPIN 5 mg single-patient-use 2-chamber cartridge</item>
                     <item>
                        <caption>â¢</caption>1 new 29 gauge (29 G), 30 gauge (30 G), or 31 gauge (31 G) Becton Dickinson pen needle</item>
                     <item>
                        <caption>â¢</caption>Alcohol swab (not included)</item>
                     <item>
                        <caption>â¢</caption>1 sharps disposal container. <content styleCode="bold">See "<linkHtml href="#IFU1_step14">Throwing away (disposing of) used needles, cartridges and your GENOTROPIN PEN 5</linkHtml>" in Step 14.</content>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Parts of the GENOTROPIN PEN 5</content> (<content styleCode="bold">See <linkHtml href="#IFU1_FigA">Figure A</linkHtml>
                     </content>)</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td valign="middle">
                              <paragraph ID="IFU1_FigA">
                                 <content styleCode="bold">Figure A</content>
                                 <br/>
                                 <renderMultiMedia ID="id-809322744" referencedObject="ID_01fb4429-0a97-43c2-8723-2f8d339195dc"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Storage instructions for your GENOTROPIN PEN 5</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Between uses, store your pen (with the cartridge) in the refrigerator 36Â°F to 46Â°F (2Â°C to 8Â°C) in its protective case. Always remove the needle before storing.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not freeze</content>. Protect from light.</item>
                     <item>
                        <caption>â¢</caption>Throw away the cartridge within 28 days after mixing, even if the cartridge is not empty.</item>
                     <item>
                        <caption>â¢</caption>When travelling, keep your pen in its protective case and carry it in an insulated bag to protect it from heat or freezing. Put your pen back in the refrigerator as soon as possible.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Using your GENOTROPIN PEN 5</content>
                  </paragraph>
                  <paragraph ID="IFU1_step1">
                     <content styleCode="bold">Step 1.</content>
                  </paragraph>
                  <paragraph>Wash your hands well with soap and water before using the GENOTROPIN PEN 5.</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="75%"/>
                     <col width="25%"/>
                     <tbody>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 2. Attach the Needle</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off the front cap (<content styleCode="bold">See <linkHtml href="#IFU1_FigB">Figure B</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigB">
                                 <content styleCode="bold">Figure B</content>
                                 <renderMultiMedia ID="id719555010" referencedObject="F2D8BD6E-7BA4-454C-BE39-FA20E9398AF3"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the metal front part from the plastic body by turning the metal front part clockwise (to the right) (<content styleCode="bold">See <linkHtml href="#IFU1_FigC">Figure C</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigC">
                                 <content styleCode="bold">Figure C</content>
                                 <renderMultiMedia ID="id-1600486570" referencedObject="D9F7FA9E-5119-4272-8A49-D8613CFD1869"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Peel off the foil from the needle.</item>
                                 <item>
                                    <caption>â¢</caption>Push and screw the needle onto the metal front part using the outer needle cover, by turning it counter clockwise (to the left) (<content styleCode="bold">See <linkHtml href="#IFU1_FigD">Figure D</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Do not remove the outer needle cover and inner needle cap until you are ready to inject.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigD">
                                 <content styleCode="bold">Figure D</content>
                                 <renderMultiMedia ID="id652257201" referencedObject="ID_8ac57018-d80c-424b-a75d-a43a88102bf5"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 3. Insert the 2-Chamber Cartridge of GENOTROPIN</content>
                                 <br/>Use only the 5 mg cartridge.</paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Open the cartridge pack and take out 1 cartridge.</item>
                                 <item>
                                    <caption>â¢</caption>Check that the color on the cartridge matches the color around the window of the plastic body (<content styleCode="bold">See <linkHtml href="#IFU1_FigE">Figure E</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigE">
                                 <content styleCode="bold">Figure E</content>
                                 <renderMultiMedia ID="id-595942003" referencedObject="ID_9c7b2c03-1c91-4f0c-8b97-dab1522f5d1b"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Hold the metal front part upright, and insert the cartridge. Insert the end of the cartridge with the metal cap first, as shown (<content styleCode="bold">See <linkHtml href="#IFU1_FigF">Figure F</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Push the cartridge firmly into place.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigF">
                                 <content styleCode="bold">Figure F</content>
                                 <renderMultiMedia ID="id1433403511" referencedObject="ID_73b64b96-d720-4b2b-ba30-6f02baf2eba9"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 4. Prepare your Pen</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button. The injection button will pop up (<content styleCode="bold">See <linkHtml href="#IFU1_FigG">Figure G</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigG">
                                 <content styleCode="bold">Figure G</content>
                                 <renderMultiMedia ID="id-1367441766" referencedObject="ID_461d2677-a6b4-4060-97d6-2ff5a067667f"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a counter clockwise direction (to the left) as far as it will go (<content styleCode="bold">See <linkHtml href="#IFU1_FigH">Figure H</linkHtml>
                                    </content>). This will draw back the plunger rod.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigH">
                                 <content styleCode="bold">Figure H</content>
                                 <renderMultiMedia ID="id924005506" referencedObject="ID_86d4258e-aece-43e4-ba8e-9232694f1ef8"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Check that the plunger rod is not visible</content> through the plunger rod window (<content styleCode="bold">See <linkHtml href="#IFU1_FigI">Figure I</linkHtml>
                                    </content>). <content styleCode="bold">Do not</content> proceed if the plunger rod is visible, as the medicine will not be properly mixed.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigI">
                                 <content styleCode="bold">Figure I</content>
                                 <renderMultiMedia ID="id625051926" referencedObject="AE41CC76-3767-4283-B1A7-71588E8B4437"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 5. Mix your GENOTROPIN</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Make sure that a needle is attached to the metal front part.</item>
                                 <item>
                                    <caption>â¢</caption>While holding your pen <content styleCode="bold">upright</content>, gently screw the metal front part and the plastic body back together as shown (<content styleCode="bold">See <linkHtml href="#IFU1_FigJ">Figure J</linkHtml>
                                    </content>). Make sure that the metal front part is firmly attached to the plastic body. This mixes the liquid and the powder.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigJ">
                                 <content styleCode="bold">Figure J</content>
                                 <renderMultiMedia ID="id1739130136" referencedObject="ID_6a9a09a9-4c78-4689-85f0-c2836ecdf8f2"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 6. Examine the Solution</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Gently tip your pen from side to side to help dissolve the powder completely (<content styleCode="bold">See <linkHtml href="#IFU1_figK">Figure K</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_figK">
                                 <content styleCode="bold">Figure K</content>
                                 <renderMultiMedia ID="id788320512" referencedObject="CE6485F7-F27F-4D7F-BE8E-2A1F5FE9D9C2"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not shake</content> your pen, as this might stop the growth hormone from working. Check that the solution (combined growth hormone powder and liquid) is clear in the cartridge window (<content styleCode="bold">See <linkHtml href="#IFU1_FigL">Figure L</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>If you see particles, or if the solution is not clear, <content styleCode="bold">do not inject</content>. Remove the cartridge and use a new one.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigL">
                                 <content styleCode="bold">Figure L</content>
                                 <renderMultiMedia ID="id-987171003" referencedObject="DAE10ABA-E691-4A28-ADED-517F9AB5F40A"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 7. Release Trapped Air</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove both the outer needle cover and inner needle cap. Throw away (dispose of) both the inner needle cap and outer needle cover. <content styleCode="bold">Do not to touch</content> the exposed needle.</item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove any trapped air from the solution as follows:</item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>a)</caption>Turn the injection button so that the white mark on the injection button lines up with the black mark on the plastic body (<content styleCode="bold">See <linkHtml href="#IFU1_FigM">Figure M</linkHtml>
                                          </content>).</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigM">
                                 <content styleCode="bold">Figure M</content>
                                 <renderMultiMedia ID="id-992016869" referencedObject="ID_7b9737b4-3e96-46de-b586-2ee0be304b7d"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>b)</caption>Hold your pen with the needle pointing <content styleCode="bold">upwards</content>. Gently tap the metal front part with your finger to move any air bubbles to the top.</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>c)</caption>Push the injection button all the way in. You will see a drop of liquid appear at the needle tip. Any trapped air has now been released (<content styleCode="bold">See <linkHtml href="#IFU1_FigN">Figure N</linkHtml>).</content>
                                       </item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigN">
                                 <content styleCode="bold">Figure N</content>
                                 <renderMultiMedia ID="id2114934408" referencedObject="ID_1426c977-b53f-46e4-aec1-250980fbf0ea"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>d)</caption>If you do not see liquid at the needle tip, press the red release button. Then turn the injection button in the direction of the arrow until it clicks 1 time, and the dose display shows '0.1'. Repeat steps b) and c) to remove any trapped air from the solution (<content styleCode="bold">see <linkHtml href="#IFU1_FigO">Figure O</linkHtml>
                                          </content>).</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigO">
                                 <content styleCode="bold">Figure O</content>
                                 <renderMultiMedia ID="id-1394353352" referencedObject="ID_4701de50-9cd4-4dec-92c3-cb144fe52768"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 8. Attach the Needle Guard (Optional)</content>
                                 <br/>The needle guard is intended to hide the needle before, during and after injection and to reduce needle injury. You can choose to use the needle guard, if desired.</paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Grip the sides of the needle guard. Push it over the needle until it snaps in place (<content styleCode="bold">See <linkHtml href="#IFU1_FigP">Figure P</linkHtml>
                                    </content>). <content styleCode="bold">Do not</content> push the needle guard on the end.<br/>Be careful not to touch the exposed needle.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigP">
                                 <content styleCode="bold">Figure P</content>
                                 <renderMultiMedia ID="id-1557474968" referencedObject="ID_0b493713-91ec-49ae-b4aa-2fe8cb9650c5"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">My daily dose is </content>
                                 <renderMultiMedia ID="id1702428157" referencedObject="ID_581efbd6-5db8-444d-9f95-532068d797fc"/>
                                 <content styleCode="bold">mg</content>
                                 <content styleCode="italics"> (write in your daily dose)</content>
                              </paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 9. Dial Your Prescribed Dose</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button to reset your pen.</item>
                                 <item>
                                    <caption>â¢</caption>The button will pop up and the dose display window will read '0.0'.</item>
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a clockwise direction (to the right) as shown, until your prescribed dose is displayed (<content styleCode="bold">See <linkHtml href="#IFU1_FigQ">Figure Q</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>If you turn the button too far, turn it back the other way until your correct dose is displayed.</item>
                              </list>
                           </td>
                           <td valign="middle">
                              <paragraph ID="IFU1_FigQ">
                                 <content styleCode="bold">Figure Q</content>
                                 <renderMultiMedia ID="id589199655" referencedObject="C00E54C8-E621-40A4-B1FC-E95728C7C402"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 10. Inject your GENOTROPIN</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Choose an injection site (thigh, buttocks, or abdomen) as recommended by your healthcare provider. Choose a different site each time you give yourself an injection. Each new injection should be given at least 1 inch from the site you used before (<content styleCode="bold">see <linkHtml href="#IFU1_FigR">Figure R</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Avoid areas that are bony, bruised, red, sore or hard. You should also avoid areas of the skin that have scars or skin problems.</item>
                                 <item>
                                    <caption>â¢</caption>Clean the injection site with the alcohol swab.</item>
                                 <item>
                                    <caption>â¢</caption>Allow the injection site to dry.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigR">
                                 <content styleCode="bold">Figure R</content>
                                 <renderMultiMedia ID="id-1594780316" referencedObject="ID_9d5faefe-9d2a-49ab-b9e8-7c14ae1f50c2"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Firmly pinch a fold of skin at the injection area. Push the needle fully into the skin fold at a 90Â° angle as shown (<content styleCode="bold">See <linkHtml href="#IFU1_FigS">Figure S</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Push the injection button until it clicks. Wait while counting <content styleCode="bold">slowly</content> for 5 seconds, and then remove the needle from the skin. This is to make sure that the entire dose has been injected (<content styleCode="bold">See <linkHtml href="#IFU1_FigS">Figure S</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigS">
                                 <content styleCode="bold">Figure S</content>
                                 <renderMultiMedia ID="id-1670255967" referencedObject="ID_29d189ee-687a-4f48-b06a-a757d5a41c66"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 11. Throw away the Needle and Store your GENOTROPIN PEN 5</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off the needle guard, gripping the sides. Be careful not to push on the end. (<content styleCode="bold">See <linkHtml href="#IFU1_FigT">Figure T</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Remove the needle as instructed by your healthcare provider, and throw it away in a sharps disposal container (<content styleCode="bold">See <linkHtml href="#IFU1_step14">Step 14</linkHtml>
                                    </content>). <content styleCode="bold">Do not reuse the needle</content>.</item>
                                 <item>
                                    <caption>â¢</caption>Push on the front cap, and put your pen back in its protective case.</item>
                                 <item>
                                    <caption>â¢</caption>Store your pen (with the cartridge) in the <content styleCode="bold">refrigerator</content> between 36ÂºF to 46ÂºF (2ÂºC to 8ÂºC) until your next injection.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigT">
                                 <content styleCode="bold">Figure T</content>
                                 <renderMultiMedia ID="id1691951560" referencedObject="F904E548-971F-43B6-9557-5001C849A416"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 12. Your Next Injection</content>
                                 <br/>If you already have a cartridge in your pen, prepare the pen and give the injection as follows:</paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove the front cap (<content styleCode="bold">See <linkHtml href="#IFU1_FigU">Figure U</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigU">
                                 <content styleCode="bold">Figure U</content>
                                 <renderMultiMedia ID="id-1661914681" referencedObject="ID_5b939951-be6f-452a-8c36-4332f8881d77"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Make sure there is enough growth hormone solution in the cartridge for your dose. Check the position of the plunger against the indicative scale in the cartridge window (<content styleCode="bold">See <linkHtml href="#IFU1_FigV">Figure V</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Peel off the foil from a needle.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigV">
                                 <content styleCode="bold">Figure V</content>
                                 <renderMultiMedia ID="id2128116629" referencedObject="ID_515224f8-b944-45a7-a2e2-9008812cdcaf"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Push and screw the needle onto the metal front part of the pen as shown (<content styleCode="bold">See <linkHtml href="#IFU1_FigW">Figure W</linkHtml>
                                    </content>). Remove the outer needle cover and inner needle cap.</item>
                                 <item>
                                    <caption>â¢</caption>Follow the instructions above, starting with <content styleCode="bold">Step 8: Attach the Needle Guard</content>.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigW">
                                 <content styleCode="bold">Figure W</content>
                                 <renderMultiMedia ID="id1907255465" referencedObject="ID_7d7ad85a-9615-4f84-a072-7f58e0fd6e51"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 13. To Replace the Cartridge</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button to reset your pen (<content styleCode="bold">See <linkHtml href="#IFU1_FigX">Figure X</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigX">
                                 <content styleCode="bold">Figure X</content>
                                 <renderMultiMedia ID="id-263380984" referencedObject="ID_0e534383-d31b-4ebc-a872-ac1d3a2169d2"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a counter clockwise direction (to the left) as far as it will go as shown (<content styleCode="bold">See <linkHtml href="#IFU1_FigY">Figure Y</linkHtml>
                                    </content>).This will draw back the plunger rod.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigY">
                                 <content styleCode="bold">Figure Y</content>
                                 <renderMultiMedia ID="id-2011371227" referencedObject="ID_8da23eb9-50f9-4625-9baf-04eb239c46d8"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the metal front part and remove the empty cartridge (<content styleCode="bold">See <linkHtml href="#IFU1_FigZ">Figure Z</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Throw away the empty cartridge as instructed by your healthcare provider.</item>
                                 <item>
                                    <caption>â¢</caption>To insert a new cartridge and prepare your pen for reuse, follow the instructions starting with <content styleCode="bold">
                                       <linkHtml href="#IFU1_step1">Step 1</linkHtml>
                                    </content>.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigZ">
                                 <content styleCode="bold">Figure Z</content>
                                 <renderMultiMedia ID="id36866137" referencedObject="F194D87A-E8B6-413E-8BE4-D8623EBE7163"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph ID="IFU1_step14">
                     <content styleCode="bold">Step 14. Throwing away (disposing of) used needles, cartridges and your GENOTROPIN PEN 5</content>
                     <br/>Put the used needles and cartridges in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) the needles and cartridges in the household trash.</paragraph>
                  <paragraph>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Made of a heavy-duty plastic,</item>
                     <item>
                        <caption>â¢</caption>Can be closed with a tight fitting, puncture-resistant lid, without sharps being able to come out,</item>
                     <item>
                        <caption>â¢</caption>Upright and stable during use,</item>
                     <item>
                        <caption>â¢</caption>Leak-resistant, and</item>
                     <item>
                        <caption>â¢</caption>Properly labeled to warn of hazardous waste inside the container.</item>
                  </list>
                  <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and cartridges. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: <linkHtml href="https://www.fda.gov/medical-devices/consumer-products/safely-using-sharps-needles-and-syringes-home-work-and-travel">http://www.fda.gov/safesharpsdisposal</linkHtml>.</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> reuse needles.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> throw away (dispose of) your used sharps disposal container in your household trash unless your community guidelines permit this.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> recycle your used sharps disposal container.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Important</content>: Always keep the sharps disposal container out of the reach of children.</paragraph>
                  <paragraph>Dispose of the entire GENOTROPIN PEN 5 as electronic waste per state and local regulations.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Customizing your Pen</content>
                  </paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="75%"/>
                     <col width="25%"/>
                     <tbody>
                        <tr>
                           <td valign="top">
                              <paragraph>Your pen is supplied with 2 colored clip-on panels, so that you can customize the look of your pen. To remove the clip-on panel from the pen, insert the lip of the front cap into the groove under the front end of the panel, and pry the panel off. The new panel simply clicks into place (<content styleCode="bold">See <linkHtml href="#IFU1_FigAA">Figure AA</linkHtml>
                                 </content>).</paragraph>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU1_FigAA">
                                 <content styleCode="bold">Figure AA</content>
                                 <renderMultiMedia ID="id1553043654" referencedObject="ID_7f60b401-955d-496a-a000-03c7f07cd602"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Caring for your Pen</content>
                     <br/>To clean your pen, wipe the outside surface with a damp cloth. Do not put the pen in water or this may damage your pen. Do not use alcohol or any other cleaning agents to clean the pen, as they may damage the plastic body. To clean the needle guard, wipe it with a damp cloth or alcohol pad.</paragraph>
                  <table width="90%">
                     <col width="45%"/>
                     <col width="55%"/>
                     <thead>
                        <tr>
                           <th align="left" styleCode="Botrule Lrule Toprule " valign="top">
                              <content styleCode="bold">Questions and Answers</content>
                           </th>
                           <th align="left" styleCode="Rrule Botrule Toprule " valign="top"/>
                        </tr>
                        <tr>
                           <th align="left" styleCode="Rrule Lrule Botrule " valign="top">
                              <content styleCode="bold">Question</content>
                           </th>
                           <th align="left" styleCode="Rrule Botrule " valign="top">
                              <content styleCode="bold">Answer</content>
                           </th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <paragraph>How long is the use period of my pen?</paragraph>
                           </td>
                           <td styleCode="Rrule Toprule Botrule " valign="top">
                              <paragraph>The pen has a use period of 2 years starting from the first use by the patient.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>How can I tell how much GENOTROPIN is left in my pen?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The indicative scale along the side of the cartridge window is a guide. The number that aligns with the front edge of the rubber stopper shows you how many milligrams are left in the cartridge. If your cartridge is nearly empty you can also dial the injection button until it cannot go any further. The dose display will then show the maximum dose that can be delivered. When the cartridge is empty, the injection button will not turn any further.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>If the display does not work, can my pen still be used?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Contact your healthcare provider as soon as possible to get a new pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>What happens if I dial the injection button beyond the maximum dose ('2.0' mg)?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Some liquid may appear from the needle tip, and the numbers may disappear from the dose display. This is normal and will not affect your injection. To correct this, turn the injection button in the opposite direction of the arrow until numbers reappear on the dose display. Then dial back to your correct dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>Why is it difficult to turn or push the injection button?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The injection button may become difficult to turn or to push. This may occur if the pen gets dirty due to contact with food, liquids or GENOTROPIN, or if the needle becomes clogged. Contact your healthcare provider if the issue does not resolve.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Display Information:</content>
                  </paragraph>
                  <table width="90%">
                     <col width="5%"/>
                     <col width="15%"/>
                     <col width="25%"/>
                     <col width="55%"/>
                     <tbody>
                        <tr>
                           <td styleCode="Botrule Lrule Toprule " valign="middle"/>
                           <td styleCode="Botrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule Toprule " valign="top">
                              <renderMultiMedia ID="id165984458" referencedObject="C7E78F18-DC4F-4BCB-B066-9A12B2D55E66"/>
                           </td>
                           <td styleCode="Rrule Botrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The selected dose size.</content>
                                 <br/>The number indicates the dose size (in mg) that your pen will deliver if the injection button is fully pressed in.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id-82295831" referencedObject="ID_5da1f667-0f69-4cac-bf18-771cd01e9786"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">A dose is not set.</content>
                                 <br/>The injection button has been turned too far in the opposite direction to the arrow on the injection button while setting the dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id327950852" referencedObject="ID_33b72856-dbbf-4a73-b250-b52845b4447d"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The injection button is rotated too fast or too slow.</content>
                                 <br/>Point your pen away from your face, press the injection button, press the red release button and continue preparing your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id-348264515" referencedObject="ID_965c31b6-ae77-46c2-b8b2-cb68d582219a"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The injection button is rotated too fast or too slow.</content>
                                 <br/>Point your pen away from your face, press the injection button, press the red release button and continue preparing your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top"/>
                           <td styleCode="Rrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">1 month before the end of the 2 year use period.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="bottom">
                              <paragraph>
                                 <content styleCode="bold">(5 seconds)</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id-1088695728" referencedObject="ID_57450d88-2e95-4a67-9f4a-a770146bd592"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>This is normal. The dose can be set and read from the display. Contact your healthcare provider as soon as possible to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="bottom">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top">
                              <renderMultiMedia ID="id-1290277696" referencedObject="ID_708ea5c5-7af6-4679-abc5-c3b60da76d5a"/>
                           </td>
                           <td styleCode="Rrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Pen has reached the end of its use period of 2 years.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="middle"/>
                           <td styleCode="Rrule Botrule " valign="middle">
                              <paragraph>The display will continue to show <renderMultiMedia ID="id-217135775" referencedObject="A27BC5E6-C233-492D-952C-C9043B0FCC8D"/> until the battery is completely empty. <br/>This does not indicate a problem with the pen. Your pen can still be used correctly, but the dose size will not be displayed. Contact your healthcare provider right away to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top"/>
                           <td rowspan="2" styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Battery charge is low and will be empty in 1 month.<br/>
                                 </content>Afterwards the dose can be set and your pen can be used correctly. Contact your healthcare provider as soon as possible to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">(5 seconds)</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id-1077824250" referencedObject="C80B0C45-9F99-437A-A572-6E42D6E79991"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id-1254353930" referencedObject="ID_9f2ec074-ebbc-486b-9ae7-e76a6c43bfc1"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Battery power low.</content>
                                 <br/>The dose cannot be displayed. Contact your healthcare provider right away to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule Lrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id487603602" referencedObject="ID_8d5955f1-3e20-4fe1-87ae-680a222b4d63"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Blank screen</content>
                                 <br/>To save the battery energy, the dose display is activated for 2 minutes and then automatically disappears. Although the display is no longer visible, the dose remains available for delivery</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider right away.</paragraph>
                  <paragraph>Use this device only for the person for whom it was prescribed.</paragraph>
                  <paragraph>
                     <content styleCode="bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Caution:</content> Federal law restricts this device to sale by or on the order of a physician.</paragraph>
                  <paragraph>Manufactured by:</paragraph>
                  <paragraph>Pharmacia &amp; Upjohn Company LLC</paragraph>
                  <paragraph>A subsidiary of Pfizer Inc.</paragraph>
                  <paragraph>New York, NY 10001</paragraph>
                  <paragraph>U.S. License No. 1216</paragraph>
                  <renderMultiMedia ID="id564465870" referencedObject="ID_42942aa1-51b2-4f48-90ee-f7d3f0fbd5ca"/>
                  <paragraph>LAB-0225-10.0</paragraph>
                  <paragraph>Revised August 2024</paragraph>
               </text>
               <effectiveTime value="20240823"/>
               <component>
                  <observationMedia ID="EF5D593F-36C6-4A87-96FC-2F7769CF827E">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_01fb4429-0a97-43c2-8723-2f8d339195dc">
                     <text>Figure A</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F2D8BD6E-7BA4-454C-BE39-FA20E9398AF3">
                     <text>Figure B</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D9F7FA9E-5119-4272-8A49-D8613CFD1869">
                     <text>Figure C</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8ac57018-d80c-424b-a75d-a43a88102bf5">
                     <text>Figure D</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9c7b2c03-1c91-4f0c-8b97-dab1522f5d1b">
                     <text>Figure E</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-07.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_73b64b96-d720-4b2b-ba30-6f02baf2eba9">
                     <text>Figure F</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-08.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_461d2677-a6b4-4060-97d6-2ff5a067667f">
                     <text>Figure G</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_86d4258e-aece-43e4-ba8e-9232694f1ef8">
                     <text>Figure H</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AE41CC76-3767-4283-B1A7-71588E8B4437">
                     <text>Figure I</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_6a9a09a9-4c78-4689-85f0-c2836ecdf8f2">
                     <text>Figure J</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-12.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="CE6485F7-F27F-4D7F-BE8E-2A1F5FE9D9C2">
                     <text>Figure K</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-13.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="DAE10ABA-E691-4A28-ADED-517F9AB5F40A">
                     <text>Figure L</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-14.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7b9737b4-3e96-46de-b586-2ee0be304b7d">
                     <text>Figure M</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-15.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_1426c977-b53f-46e4-aec1-250980fbf0ea">
                     <text>Figure N</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-16.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_4701de50-9cd4-4dec-92c3-cb144fe52768">
                     <text>Figure O</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-17.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_0b493713-91ec-49ae-b4aa-2fe8cb9650c5">
                     <text>Figure P</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-18.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_581efbd6-5db8-444d-9f95-532068d797fc">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-18a.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C00E54C8-E621-40A4-B1FC-E95728C7C402">
                     <text>Figure Q</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-19.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9d5faefe-9d2a-49ab-b9e8-7c14ae1f50c2">
                     <text>Figure R</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-20.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_29d189ee-687a-4f48-b06a-a757d5a41c66">
                     <text>Figure S</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-21.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F904E548-971F-43B6-9557-5001C849A416">
                     <text>Figure T</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-22.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5b939951-be6f-452a-8c36-4332f8881d77">
                     <text>Figure U</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-23.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_515224f8-b944-45a7-a2e2-9008812cdcaf">
                     <text>Figure V</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-24.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7d7ad85a-9615-4f84-a072-7f58e0fd6e51">
                     <text>Figure W</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-25.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_0e534383-d31b-4ebc-a872-ac1d3a2169d2">
                     <text>Figure X</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-26.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8da23eb9-50f9-4625-9baf-04eb239c46d8">
                     <text>Figure Y</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-27.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F194D87A-E8B6-413E-8BE4-D8623EBE7163">
                     <text>Figure Z</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-28.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7f60b401-955d-496a-a000-03c7f07cd602">
                     <text>Figure AA</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-29.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C7E78F18-DC4F-4BCB-B066-9A12B2D55E66">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-30.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5da1f667-0f69-4cac-bf18-771cd01e9786">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-31.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_33b72856-dbbf-4a73-b250-b52845b4447d">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-32.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_965c31b6-ae77-46c2-b8b2-cb68d582219a">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-33.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_57450d88-2e95-4a67-9f4a-a770146bd592">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-34.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_708ea5c5-7af6-4679-abc5-c3b60da76d5a">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-35.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A27BC5E6-C233-492D-952C-C9043B0FCC8D">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-35a.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C80B0C45-9F99-437A-A572-6E42D6E79991">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-36.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9f2ec074-ebbc-486b-9ae7-e76a6c43bfc1">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-37.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8d5955f1-3e20-4fe1-87ae-680a222b4d63">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-38.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_42942aa1-51b2-4f48-90ee-f7d3f0fbd5ca">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-39.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_e338833e-7cd7-4aac-bd5e-05b1225376ca">
               <id root="5d46e979-6466-4981-80be-26f8ea0c8c88"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <text>
                  <renderMultiMedia ID="id4193" referencedObject="MM14"/>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                     <br/>
                     <content styleCode="bold">GENOTROPIN 12 (JEEN-o-tro-pin 12)</content>
                     <br/>
                     <content styleCode="bold">GENOTROPIN PEN 12 is a medical device used to mix and inject doses of reconstituted GENOTROPIN (somatropin) for injection. Use this device only for administration of GENOTROPIN.</content>
                  </paragraph>
                  <table width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Important Note</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top">
                              <paragraph>Please read these instructions completely before using the GENOTROPIN PEN 12. These instructions need to be followed step by step. Please do not use the GENOTROPIN PEN 12 unless your healthcare provider has trained you. If there is anything you do not understand or cannot do, call the Pfizer Bridge Program toll-free number at 1-800-645-1280. If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>Your pen should not be used near electrical or electronic equipment, including mobile phones. If your pen has been damaged, it should not be used and should be disposed of as instructed by your healthcare provider.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>GENOTROPIN PEN 12 is a reusable multi-dose device holding a 2-chamber cartridge of GENOTROPIN, used to mix and inject GENOTROPIN during a 2 year use period.</paragraph>
                  <paragraph>
                     <content styleCode="bold">For your injection you will need:</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>1 GENOTROPIN PEN 12 device</item>
                     <item>
                        <caption>â¢</caption>1 GENOTROPIN 12 mg single-patient-use 2-chamber cartridge</item>
                     <item>
                        <caption>â¢</caption>1 new 29 gauge (29 G), 30 gauge (30 G), or 31 gauge (31 G) Becton Dickinson pen needle</item>
                     <item>
                        <caption>â¢</caption>Alcohol swab (not included)</item>
                     <item>
                        <caption>â¢</caption>1 sharps disposal container. <content styleCode="bold">See "<linkHtml href="#IFU2_Step14">Throwing away (disposing of) used needles, cartridges and your GENOTROPIN PEN 12</linkHtml>" in Step 14.</content>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Parts of the GENOTROPIN PEN 12</content> (<content styleCode="bold">See <linkHtml href="#IFU2_FigA">Figure A</linkHtml>
                     </content>)</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td align="center" valign="middle">
                              <paragraph ID="IFU2_FigA">
                                 <content styleCode="bold">Figure A</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <renderMultiMedia ID="id4228" referencedObject="MM15"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Storage instructions for your GENOTROPIN PEN 12</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Between uses, store your pen (with the cartridge) in the refrigerator between 36Â°F to 46Â°F (2Â°C to 8Â°C) in its protective case. Always remove the needle before storing.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not freeze.</content> Protect from light.</item>
                     <item>
                        <caption>â¢</caption>Throw away the cartridge within 28 days after mixing, even if the cartridge is not empty.</item>
                     <item>
                        <caption>â¢</caption>When travelling, keep your pen in its protective case and carry it in an insulated bag to protect it from heat or freezing. Put your pen back in the refrigerator as soon as possible.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Using your GENOTROPIN PEN 12</content>
                  </paragraph>
                  <paragraph ID="IFU2_Step1">
                     <content styleCode="bold">Step 1.</content>
                     <br/>Wash your hands well with soap and water before using the GENOTROPIN PEN 12.</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="75%"/>
                     <col width="25%"/>
                     <tbody>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 2. Attach the Needle</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off the front cap (<content styleCode="bold">See <linkHtml href="#IFU2_FigB">Figure B</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigB">
                                 <content styleCode="bold">Figure B</content>
                                 <renderMultiMedia ID="figb2" referencedObject="MM16"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the metal front part from the plastic body by turning the metal front part clockwise (to the right) (<content styleCode="bold">See <linkHtml href="#IFU2_FigC">Figure C</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigC">
                                 <content styleCode="bold">Figure C</content>
                                 <renderMultiMedia ID="figc2" referencedObject="MM17"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Peel off the foil from the needle.</item>
                                 <item>
                                    <caption>â¢</caption>Push and screw the needle onto the metal front part using the outer needle cover, by turning it counter clockwise (to the left) (<content styleCode="bold">See <linkHtml href="#IFU2_FigD">Figure D</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Do not remove the outer needle cover and inner needle cap until you are ready to inject.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigD">
                                 <content styleCode="bold">Figure D</content>
                                 <renderMultiMedia ID="figd2" referencedObject="MM18"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 3. Insert the 2-Chamber Cartridge of GENOTROPIN</content>
                                 <br/>Use only the 12 mg cartridge.</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Open the cartridge pack and take out 1 cartridge.</item>
                                 <item>
                                    <caption>â¢</caption>Check that the color on the cartridge matches the color around the window of the plastic body (<content styleCode="bold">See <linkHtml href="#IFU2_FigE">Figure E</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigE">
                                 <content styleCode="bold">Figure E</content>
                                 <renderMultiMedia ID="fige2" referencedObject="MM19"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Hold the metal front part upright, and insert the cartridge. Insert the end of the cartridge with the metal cap first, as shown (<content styleCode="bold">See <linkHtml href="#IFU2_FigF">Figure F</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Push the cartridge firmly into place.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigF">
                                 <content styleCode="bold">Figure F</content>
                                 <renderMultiMedia ID="figf2" referencedObject="MM20"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Step 4. Prepare the Pen</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button. The injection button will pop up (<content styleCode="bold">See <linkHtml href="#IFU2_FigG">Figure G</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="middle">
                              <paragraph ID="IFU2_FigG">
                                 <content styleCode="bold">Figure G</content>
                                 <renderMultiMedia ID="figg2" referencedObject="MM21"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a counter clockwise direction (to the left) as far as it will go (<content styleCode="bold">See <linkHtml href="#IFU2_FigH">Figure H</linkHtml>
                                    </content>). This will draw back the plunger rod.</item>
                              </list>
                           </td>
                           <td align="center" valign="middle">
                              <paragraph ID="IFU2_FigH">
                                 <content styleCode="bold">Figure H</content>
                                 <renderMultiMedia ID="figh2" referencedObject="MM22"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="middle">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Check that the plunger rod is not visible</content> through the plunger rod window (<content styleCode="bold">See <linkHtml href="#IFU2_FigI">Figure I</linkHtml>
                                    </content>). <content styleCode="bold">Do not</content> proceed if the plunger rod is visible, as the medicine will not be properly mixed.</item>
                              </list>
                           </td>
                           <td align="center" valign="middle">
                              <paragraph ID="IFU2_FigI">
                                 <content styleCode="bold">Figure I</content>
                                 <renderMultiMedia ID="figi2" referencedObject="MM23"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 5. Mix your GENOTROPIN</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Make sure that a needle is attached to the metal front part.</item>
                                 <item>
                                    <caption>â¢</caption>While holding your pen <content styleCode="bold">upright</content>, gently screw the metal front part and the plastic body back together as shown (<content styleCode="bold">See <linkHtml href="#IFU2_FigJ">Figure J</linkHtml>
                                    </content>). Make sure that the metal front part is firmly attached to the plastic body. This mixes the liquid and the powder.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigJ">
                                 <content styleCode="bold">Figure J</content>
                                 <renderMultiMedia ID="figj2" referencedObject="MM24"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 6. Examine the Solution</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Gently tip the pen from side to side to help dissolve the powder completely (<content styleCode="bold">See <linkHtml href="#IFU2_FigK">Figure K</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigK">
                                 <content styleCode="bold">Figure K</content>
                                 <renderMultiMedia ID="figk2" referencedObject="MM25"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not shake your pen</content>, as this might stop the growth hormone from working. Check that the solution (combined growth hormone powder and liquid) is clear in the cartridge window (<content styleCode="bold">See <linkHtml href="#IFU2_FigL">Figure L</linkHtml>
                                    </content>).</item>
                              </list>
                              <paragraph>If you see particles, or if the solution is not clear, <content styleCode="bold">do not inject</content>. Remove the cartridge and use a new one.</paragraph>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigL">
                                 <content styleCode="bold">Figure L</content>
                                 <renderMultiMedia ID="figl2" referencedObject="MM26"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 7. Release Trapped Air</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove both the outer needle cover and inner needle cap. Throw away (dispose of) both the inner needle cap and outer needle cover. <content styleCode="bold">Do not touch</content> the exposed needle.</item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove any trapped air from the solution as follows:</item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>a)</caption>Turn the injection button so that the white mark on the injection button lines up with the black mark on the plastic body (<content styleCode="bold">See <linkHtml href="#IFU2_FigM">Figure M</linkHtml>
                                          </content>).</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigM">
                                 <content styleCode="bold">Figure M</content>
                                 <renderMultiMedia ID="figm2" referencedObject="MM27"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>b)</caption>Hold your pen with the needle pointing <content styleCode="bold">upwards</content> (<content styleCode="bold">See <linkHtml href="#IFU2_FigN">Figure N</linkHtml>
                                          </content>). Gently tap the metal front part with your finger to move any air bubbles to the top.</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td align="center" rowspan="2" valign="top">
                              <paragraph ID="IFU2_FigN">
                                 <content styleCode="bold">Figure N</content>
                                 <renderMultiMedia ID="fign2" referencedObject="MM28"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>c)</caption>Push the injection button all the way in. You will see a drop of liquid appear at the needle tip. Any trapped air has now been released (<content styleCode="bold">See <linkHtml href="#IFU2_FigN">Figure N</linkHtml>
                                          </content>).</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>d)</caption>If you do not see liquid at the needle tip, press the red release button. Then turn the injection button in the direction of the arrow until it clicks 1 time, and the dose display shows '0.2'. Repeat steps b) and c) to remove any trapped air from the solution (<content styleCode="bold">See <linkHtml href="#IFU2_FigO">Figure O</linkHtml>
                                          </content>).</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigO">
                                 <content styleCode="bold">Figure O</content>
                                 <renderMultiMedia ID="figo2" referencedObject="MM29"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 8. Attach the Needle Guard (Optional)</content>
                                 <br/>The needle guard is intended to hide the needle before, during and after injection and to reduce needle injury. You can choose to use the needle guard, if desired.</paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Grip the sides of the needle guard. Push it over the needle until it snaps in place (<content styleCode="bold">See <linkHtml href="#IFU2_FigP">Figure P</linkHtml>
                                    </content>). <content styleCode="bold">Do not</content> push the needle guard on the end.</item>
                              </list>
                              <paragraph>Be careful not to touch the exposed needle.</paragraph>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigP">
                                 <content styleCode="bold">Figure P</content>
                                 <renderMultiMedia ID="figp2" referencedObject="MM30"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">My daily dose is </content>
                                 <renderMultiMedia ID="id4413" referencedObject="MM31"/>
                                 <content styleCode="bold">mg</content>
                                 <content styleCode="italics"> (write in your daily dose)</content>
                              </paragraph>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 9. Dial Your Prescribed Dose</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button to reset your pen.</item>
                                 <item>
                                    <caption>â¢</caption>The button will pop up and the dose display window will read '0.0'.</item>
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a clockwise direction (to the right) as shown until your prescribed dose is displayed (<content styleCode="bold">See <linkHtml href="#IFU2_FigQ">Figure Q</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>If you turn the button too far, turn it back the other way until your correct dose is displayed.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigQ">
                                 <content styleCode="bold">Figure Q</content>
                                 <renderMultiMedia ID="figq2" referencedObject="MM32"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 10. Inject your GENOTROPIN</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Choose an injection site (thigh, buttocks, or abdomen) as recommended by your healthcare provider. Choose a different site each time you give yourself an injection. Each new injection should be given at least 1 inch from the site you used before (<content styleCode="bold">See <linkHtml href="#IFU2_FigR">Figure R</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Avoid areas that are bony, bruised, red, sore or hard, and areas of the skin that have scars or skin conditions.</item>
                                 <item>
                                    <caption>â¢</caption>Clean the injection site with the alcohol swab.</item>
                                 <item>
                                    <caption>â¢</caption>Allow the injection site to dry.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigR">
                                 <content styleCode="bold">Figure R</content>
                                 <renderMultiMedia ID="figr2" referencedObject="MM33"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Firmly pinch a fold of skin at the injection area. Push the needle fully into the skin fold at a 90Â° angle as shown (<content styleCode="bold">See <linkHtml href="#IFU2_FigS">Figure S</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Push the injection button until it clicks. Wait while counting <content styleCode="bold">slowly</content> for 5 seconds, and then remove the needle from the skin. This is to make sure that the entire dose has been injected (<content styleCode="bold">See <linkHtml href="#IFU2_FigS">Figure S</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigS">
                                 <content styleCode="bold">Figure S</content>
                                 <renderMultiMedia ID="figs2" referencedObject="MM34"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 11. Throw away the Needle and Store the GENOTROPIN PEN 12</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off the needle guard, gripping the sides. Be careful not to push on the end (<content styleCode="bold">See <linkHtml href="#IFU2_FigT">Figure T</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Remove the needle as instructed by your healthcare provider, and throw it away in a sharps disposal container (<content styleCode="bold">See <linkHtml href="#IFU2_Step14">Step 14</linkHtml>
                                    </content>). <content styleCode="bold">Do not reuse the needle</content>.</item>
                                 <item>
                                    <caption>â¢</caption>Push on the front cap, and put your pen back in its protective case.</item>
                                 <item>
                                    <caption>â¢</caption>Store your pen (with the cartridge) in the <content styleCode="bold">refrigerator</content> between 36Â°F to 46Â°F (2Â°C to 8Â°C) until your next injection.</item>
                              </list>
                           </td>
                           <td align="center" valign="middle">
                              <paragraph ID="IFU2_FigT">
                                 <content styleCode="bold">Figure T</content>
                                 <renderMultiMedia ID="figt2" referencedObject="MM35"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 12. Your Next Injection</content>
                                 <br/>If you already have a cartridge in your pen, prepare the pen and give the injection as follows:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove the front cap (<content styleCode="bold">See <linkHtml href="#IFU2_FigU">Figure U</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigU">
                                 <content styleCode="bold">Figure U</content>
                                 <renderMultiMedia ID="figu2" referencedObject="MM36"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Make sure there is enough growth hormone solution in the cartridge for your dose. Check the position of the plunger against the indicative scale in the cartridge window (<content styleCode="bold">See <linkHtml href="#IFU2_FigV">Figure V</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Peel off the foil from a needle.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigV">
                                 <content styleCode="bold">Figure V</content>
                                 <renderMultiMedia ID="figv2" referencedObject="MM37"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Push and screw the needle onto the metal front part of your pen as shown (<content styleCode="bold">See <linkHtml href="#IFU2_FigW">Figure W</linkHtml>
                                    </content>). Remove the outer needle cover and inner needle cap.</item>
                                 <item>
                                    <caption>â¢</caption>Follow the instructions above, starting with <content styleCode="bold">Step 8: Attach the Needle Guard</content>.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigW">
                                 <content styleCode="bold">Figure W</content>
                                 <renderMultiMedia ID="figw2" referencedObject="MM38"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 13. To Replace the Cartridge</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Press the red release button to reset your pen (<content styleCode="bold">See <linkHtml href="#IFU2_FigX">Figure X</linkHtml>
                                    </content>).</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigX">
                                 <content styleCode="bold">Figure X</content>
                                 <renderMultiMedia ID="figx2" referencedObject="MM39"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Turn the injection button in a counter clockwise direction (to the left) as far as it will go as shown (<content styleCode="bold">See <linkHtml href="#IFU2_FigY">Figure Y</linkHtml>
                                    </content>). This will draw back the plunger rod.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigY">
                                 <content styleCode="bold">Figure Y</content>
                                 <renderMultiMedia ID="figy2" referencedObject="MM40"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the metal front part and remove the empty cartridge (<content styleCode="bold">See <linkHtml href="#IFU2_FigZ">Figure Z</linkHtml>
                                    </content>).</item>
                                 <item>
                                    <caption>â¢</caption>Throw away the empty cartridge as instructed by your healthcare provider.</item>
                                 <item>
                                    <caption>â¢</caption>To insert a new cartridge and prepare your pen for reuse, follow the instructions starting with <content styleCode="bold">
                                       <linkHtml href="#IFU2_Step1">Step 1</linkHtml>
                                    </content>.</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigZ">
                                 <content styleCode="bold">Figure Z</content>
                                 <renderMultiMedia ID="figz2" referencedObject="MM41"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph ID="IFU2_Step14">
                     <content styleCode="bold">Step 14. Throwing away (disposing of) used needles, cartridges and your GENOTROPIN PEN 12</content>
                     <br/>Put the used needles and cartridges in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) the needles and cartridges in the household trash.</paragraph>
                  <paragraph>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Made of a heavy-duty plastic,</item>
                     <item>
                        <caption>â¢</caption>Can be closed with a tight fitting, puncture-resistant lid, without sharps being able to come out,</item>
                     <item>
                        <caption>â¢</caption>Upright and stable during use,</item>
                     <item>
                        <caption>â¢</caption>Leak-resistant, and</item>
                     <item>
                        <caption>â¢</caption>Properly labeled to warn of hazardous waste inside the container.</item>
                  </list>
                  <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and cartridges. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: <linkHtml href="https://www.fda.gov/medical-devices/consumer-products/safely-using-sharps-needles-and-syringes-home-work-and-travel">http://www.fda.gov/safesharpsdisposal</linkHtml>.</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> reuse needles.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> throw away (dispose of) your used sharps disposal container in your household trash unless your community guidelines permit this.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> recycle your used sharps disposal container.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Important</content>: Always keep the sharps disposal container out of the reach of children.</paragraph>
                  <paragraph>Dispose of the entire GENOTROPIN PEN 12 as electronic waste per state and local regulations.</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="75%"/>
                     <col width="25%"/>
                     <tbody>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Customizing your Pen</content>
                                 <br/>Your pen is supplied with 2 colored clip-on panels, so that you can customize the look of your pen. To remove the clip-on panel from your pen, insert the lip of the front cap into the groove under the front end of the panel, and pry the panel off. The new panel simply clicks into place (<content styleCode="bold">See <linkHtml href="#IFU2_FigAA">Figure AA</linkHtml>
                                 </content>).</paragraph>
                           </td>
                           <td align="center" valign="top">
                              <paragraph ID="IFU2_FigAA">
                                 <content styleCode="bold">Figure AA</content>
                                 <renderMultiMedia ID="figaa2" referencedObject="MM42"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Caring for your Pen</content>
                  </paragraph>
                  <paragraph>To clean your pen, wipe the outside surface with a damp cloth. Do not put the pen in water as this may damage your pen. Do not use alcohol or any other cleaning agents to clean the pen, as they may damage the plastic body. To clean the needle guard, wipe it with a damp cloth or alcohol pad.</paragraph>
                  <table width="90%">
                     <col width="45%"/>
                     <col width="55%"/>
                     <thead>
                        <tr>
                           <th align="left" styleCode="Botrule Lrule Toprule " valign="top">
                              <content styleCode="bold">Questions and Answers</content>
                           </th>
                           <th align="left" styleCode="Rrule Botrule Toprule " valign="top"/>
                        </tr>
                        <tr>
                           <th align="left" styleCode="Rrule Lrule Botrule " valign="top">
                              <content styleCode="bold">Question</content>
                           </th>
                           <th align="left" styleCode="Rrule Botrule " valign="top">
                              <content styleCode="bold">Answer</content>
                           </th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <paragraph>How long is the use period of my pen?</paragraph>
                           </td>
                           <td styleCode="Rrule Toprule Botrule " valign="top">
                              <paragraph>The pen has a use period of 2 years starting from the first use by the patient.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>How can I tell how much GENOTROPIN is left in my pen?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The indicative scale along the side of the cartridge window is a guide. The number that aligns with the front edge of the rubber stopper shows you how many milligrams are left in the cartridge. If your cartridge is nearly empty you can also dial the injection button until it cannot go any further, the dose display will then show the maximum dose that can be delivered. When the cartridge is empty, the injection button will not turn any further.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>If the display does not work, can my pen still be used?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Contact your healthcare provider as soon as possible to get a new pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>What happens if I dial the injection button beyond the maximum dose ('4.0' mg)?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Some liquid may appear from the needle tip, and the numbers may disappear from the dose display. This is normal and will not affect your injection. To correct this, turn the injection button in the opposite direction of the arrow until numbers reappear on the dose display. Then dial back to your correct dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>Why is it difficult to turn or push the injection button?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The injection button may become difficult to turn or to push. This may occur if the pen gets dirty due to contact with food, liquids or GENOTROPIN, or if the needle becomes clogged. Contact your healthcare provider if the issue does not resolve.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Display Information</content>
                  </paragraph>
                  <table width="90%">
                     <col width="5%"/>
                     <col width="15%"/>
                     <col width="25%"/>
                     <col width="55%"/>
                     <tbody>
                        <tr>
                           <td styleCode="Botrule Lrule Toprule " valign="middle"/>
                           <td styleCode="Botrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule Toprule " valign="top">
                              <renderMultiMedia ID="id4614" referencedObject="MM43"/>
                           </td>
                           <td styleCode="Rrule Botrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The selected dose size.</content>
                                 <br/>The number indicates the dose size (in mg) that your pen will deliver if the injection button is fully pressed in.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4623" referencedObject="MM44"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">A dose is not set.</content>
                                 <br/>The injection button has been turned too far in the opposite direction to the arrow on the injection button while setting the dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4632" referencedObject="MM45"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The injection button is rotated too fast or too slow.</content>
                                 <br/>Point the pen away from your face, press the injection button, press the red release button and continue preparing your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4641" referencedObject="MM46"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">The injection button is rotated too fast or too slow.</content>
                                 <br/>Point the pen away from your face, press the injection button, press the red release button and continue preparing your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top"/>
                           <td styleCode="Rrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">1 month before the end of the 2 year use period.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="bottom">
                              <paragraph>
                                 <content styleCode="bold">(5 seconds)</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4657" referencedObject="MM47"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>This is normal. The dose can be set and read from the display. Contact your healthcare provider as soon as possible to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="bottom">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top">
                              <renderMultiMedia ID="id4664" referencedObject="MM48"/>
                           </td>
                           <td styleCode="Rrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Pen has reached the end of its use period of 2 years.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="middle"/>
                           <td styleCode="Rrule Botrule " valign="middle">
                              <paragraph>The display will continue to show <renderMultiMedia ID="id4670" referencedObject="MM49"/> until the battery is completely empty. This does not indicate a problem with your pen. Your pen can still be used correctly, but the dose size will not be displayed. Contact your healthcare provider right away to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule " valign="middle"/>
                           <td valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Flashing</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule " valign="top"/>
                           <td styleCode="Rrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Battery charge is low and will be empty in 1 month.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">(5 seconds)</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4684" referencedObject="MM50"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Afterwards the dose can be set and your pen can be used correctly. Contact your healthcare provider as soon as possible to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Lrule Botrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4691" referencedObject="MM51"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Battery power low.</content>
                                 <br/>The dose cannot be displayed. Contact your healthcare provider right away to get a new Pen.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Botrule Lrule " valign="middle"/>
                           <td styleCode="Botrule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Steady</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <renderMultiMedia ID="id4700" referencedObject="MM52"/>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Blank screen</content>
                                 <br/>To save the battery energy, the dose display is activated for 2 minutes and then automatically disappears. Although the display is no longer visible, the dose remains available for delivery.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider right away.</paragraph>
                  <paragraph>Use this device only for the person for whom it was prescribed.</paragraph>
                  <paragraph>
                     <content styleCode="bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                     <br/>
                     <content styleCode="bold">Caution:</content> Federal law restricts this device to sale by or on the order of a physician.</paragraph>
                  <paragraph>Manufactured by:<br/>Pharmacia &amp; Upjohn Company LLC<br/>A subsidiary of Pfizer Inc.<br/>New York, NY 10001<br/>U.S. License No. 1216<br/>
                  </paragraph>
                  <renderMultiMedia ID="id713700639" referencedObject="ID_3dc289dc-e6b3-4603-86dd-f888ed43e829"/>
                  <paragraph>LAB-0224-10.0</paragraph>
                  <paragraph>Revised August 2024</paragraph>
               </text>
               <effectiveTime value="20240823"/>
               <component>
                  <observationMedia ID="MM14">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-40.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM15">
                     <text>Figure A</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-41.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM16">
                     <text>Figure B</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-42.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM17">
                     <text>Figure C</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-43.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM18">
                     <text>Figure D</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-44.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM19">
                     <text>Figure E</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-45.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM20">
                     <text>Figure F</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-46.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM21">
                     <text>Figure G</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-47.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM22">
                     <text>Figure H</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-48.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM23">
                     <text>Figure I</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-49.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM24">
                     <text>Figure J</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-50.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM25">
                     <text>Figure K</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-51.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM26">
                     <text>Figure L</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-52.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM27">
                     <text>Figure M</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-53.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM28">
                     <text>Figure N</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-54.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM29">
                     <text>Figure O</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-55.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM30">
                     <text>Figure P</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-56.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM31">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-56a.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM32">
                     <text>Figure Q</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-57.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM33">
                     <text>Figure R</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-58.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM34">
                     <text>Figure S</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-59.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM35">
                     <text>Figure T</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-60.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM36">
                     <text>Figure U</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-61.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM37">
                     <text>Figure V</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-62.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM38">
                     <text>Figure W</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-63.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM39">
                     <text>Figure X</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-64.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM40">
                     <text>Figure Y</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-65.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM41">
                     <text>Figure Z</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-66.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM42">
                     <text>Figure AA</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-67.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM43">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-68.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM44">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-69.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM45">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-70.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM46">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-71.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM47">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-72.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM48">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-73.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM49">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-73a.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM50">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-74.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM51">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-75.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM52">
                     <text>Image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-76.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3dc289dc-e6b3-4603-86dd-f888ed43e829">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-77.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_c3441a57-be31-4c1b-a3f5-4fc2916132f5">
               <id root="526b24be-b332-47a4-8b0a-22ef206280fb"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE<br/>GENOTROPIN MINIQUICK (JEEN-o-tro-pin MIN-ee-kwik)<br/>Growth Hormone Delivery Device containing GENOTROPIN<sup>Â®</sup> (somatropin) for injection</content>
                  </paragraph>
                  <table width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td styleCode="Rrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Important Note</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top">
                              <paragraph>Please read these instructions completely before using GENOTROPIN MINIQUICK. If there is anything you do not understand or cannot do, call the Pfizer Bridge Program toll-free number at 1-800-645-1280.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>GENOTROPIN MINIQUICK is available in 10 dose strengths. <content styleCode="bold">Check your GENOTROPIN MINIQUICK to be sure you have the dose your healthcare provider prescribed.</content>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>GENOTROPIN MINIQUICK is a device holding a 2-chamber cartridge of GENOTROPIN, used to mix and inject a single dose of GENOTROPIN.</paragraph>
                  <paragraph>
                     <content styleCode="bold">For each injection you will need:</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>2 alcohol pads (not included)</item>
                     <item>
                        <caption>â¢</caption>1 GENOTROPIN MINIQUICK device with the singleâdose 2-chamber cartridge of GENOTROPIN inside. The 2-chamber cartridge of GENOTROPIN contains the growth hormone powder in one chamber and the liquid in the other.</item>
                     <item>
                        <caption>â¢</caption>1 injection needle. A needle for injection is provided with each device. If you need additional needles, ask your healthcare provider for a 29 gauge (29 G), 30 gauge (30 G), or 31 gauge (31 G) Becton Dickinson pen needle.</item>
                     <item>
                        <caption>â¢</caption>1 sharps disposal container (not included). <content styleCode="bold">See "<linkHtml href="#IFU3_Step12">Throwing away (disposing of) your GENOTROPIN MINIQUICK and needles</linkHtml>" in Step 12.</content>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Parts of the GENOTROPIN MINIQUICK</content> (<content styleCode="bold">See <linkHtml href="#IFU3_FigA">Figure A</linkHtml>
                     </content>)</paragraph>
                  <renderMultiMedia ID="id8880040" referencedObject="F8424B89-4396-462D-9A72-9CA527A2324B"/>
                  <paragraph>
                     <content styleCode="bold">Storage instructions for your GENOTROPIN MINIQUICK</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Keep your GENOTROPIN MINIQUICK in the original carton to protect it from light.</item>
                     <item>
                        <caption>â¢</caption>Before you mix the growth hormone powder with the liquid in the syringe, you can store the GENOTROPIN MINIQUICK in the refrigerator between 36ÂºF to 46ÂºF (2ÂºC to 8ÂºC). You can also store the GENOTROPIN MINIQUICK at room temperature between 68ÂºF to 77ÂºF (20ÂºC to 25ÂºC) for up to 3 months. <content styleCode="bold">Do not freeze.</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Inject the GENOTROPIN right after you mix it. If that is not possible, you can keep the GENOTROPIN MINIQUICK in the refrigerator between 36ÂºF to 46ÂºF (2ÂºC to 8ÂºC) for up to 24 hours after mixing it. <content styleCode="bold">Do not freeze.</content>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Using your GENOTROPIN MINIQUICK</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Step 1.</content>
                     <br/>Wash your hands well with soap and water before using the GENOTROPIN MINIQUICK.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Step 2.</content>
                     <br/>Open the plastic bag that contains your GENOTROPIN MINIQUICK by tearing the bag along the dotted lines on the plastic.</paragraph>
                  <table styleCode="Noautorules" width="100%">
                     <col width="70%"/>
                     <col width="30%"/>
                     <tbody>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 3.</content>
                                 <br/>Wipe the rubber stopper on the GENOTROPIN MINIQUICK with an alcohol pad. (<content styleCode="bold">See <linkHtml href="#IFU3_FigB">Figure B</linkHtml>
                                 </content>)</paragraph>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigB">
                                 <content styleCode="bold">Figure B</content>
                                 <renderMultiMedia ID="id-1104417710" referencedObject="ID_58b41065-ee5c-4c55-8cec-e153c02468a0"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 4.</content>
                                 <br/>Peel the seal from the back of the injection needle. Leave both the inner needle cover and the outer needle cover on the needle. (<content styleCode="bold">See <linkHtml href="#IFU3_FigC">Figure C</linkHtml>
                                 </content>)</paragraph>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigC">
                                 <content styleCode="bold">Figure C</content>
                                 <renderMultiMedia ID="id1885757587" referencedObject="BAA6DFD8-C784-4428-9D47-568F8B7F8B28"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 5.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Attach the needle onto the GENOTROPIN MINIQUICK by pushing it down and turning it clockwise (to the right) until it will no longer turn.</item>
                                 <item>
                                    <caption>â¢</caption>Make sure the needle is placed directly over the rubber stopper (not at an angle), before screwing the needle onto the rubber stopper of the GENOTROPIN MINIQUICK. (<content styleCode="bold">See <linkHtml href="#IFU3_FigD">Figure D</linkHtml>
                                    </content>)</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigD">
                                 <content styleCode="bold">Figure D</content>
                                 <renderMultiMedia ID="id1089197656" referencedObject="ID_85418c8a-6212-4bb6-adc3-6b80b4c15206"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 6.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Hold the GENOTROPIN MINIQUICK with the needle pointing up. Turn the plunger rod clockwise (to the right) until it will not go any further. (<content styleCode="bold">See <linkHtml href="#IFU3_FigE">Figure E</linkHtml>
                                    </content>) This will automatically mix the growth hormone powder and the liquid.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not shake</content> the GENOTROPIN MINIQUICK. Shaking may cause the growth hormone to not work as well.</item>
                                 <item>
                                    <caption>â¢</caption>Make sure the solution (combined growth hormone powder and liquid) is clear, and that the growth hormone powder is completely dissolved. If you see particles in the solution, or if the solution is discolored, <content styleCode="bold">do not inject it</content>. Call the Pfizer Bridge Program at 1-800-645-1280.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigE">
                                 <content styleCode="bold">Figure E</content>
                                 <renderMultiMedia ID="id1739970464" referencedObject="ID_21300134-71e2-421f-959c-eda8442d7508"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 7.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Choose an injection site (thigh, buttocks, or abdomen) as recommended by your healthcare provider. Choose a different site each time you give yourself an injection. Each new injection should be at least 1 inch from the site you used before (<content styleCode="bold">See <linkHtml href="#IFU3_FigF">Figure F</linkHtml>
                                    </content>).<br/>Avoid areas that are bony, bruised, red, sore or hard. You should also avoid areas that have scars or skin problems.</item>
                                 <item>
                                    <caption>â¢</caption>Clean the injection site with the alcohol swab. Allow the injection site to dry.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigF">
                                 <content styleCode="bold">Figure F</content>
                                 <renderMultiMedia ID="id2125959706" referencedObject="A9F933FB-0610-4639-AB40-7A97922A03C0"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 8.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove the outer needle cover and the inner needle cover from the needle. <content styleCode="bold">Save the outer needle cover.</content> (<content styleCode="bold">See <linkHtml href="#IFU3_FigG">Figure G</linkHtml>
                                    </content>)</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigG">
                                 <content styleCode="bold">Figure G</content>
                                 <renderMultiMedia ID="id1443798535" referencedObject="A8B67C82-DE80-4C06-ADC4-BA184AE6EBBE"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 9.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pinch a fold of skin at the injection site firmly, and push the needle straight into the skin at a 90Â°angle. (<content styleCode="bold">See <linkHtml href="#IFU3_FigH">Figure H</linkHtml>
                                    </content>)</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigH">
                                 <content styleCode="bold">Figure H</content>
                                 <renderMultiMedia ID="id-623763023" referencedObject="B699686F-FE4D-40F6-85EF-E42FDAC7CFEC"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 10.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Push the plunger rod in as far as it will go, to inject all of the medicine in the GENOTROPIN MINIQUICK into the fold of skin. (<content styleCode="bold">See <linkHtml href="#IFU3_FigI">Figure I</linkHtml>
                                    </content>)</item>
                                 <item>
                                    <caption>â¢</caption>Wait a few seconds to be sure that all of the growth hormone solution has been injected. Pull out the needle.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigI">
                                 <content styleCode="bold">Figure I</content>
                                 <renderMultiMedia ID="id-780339059" referencedObject="ID_30914782-9e36-4e29-87ee-2d279ea8fd98"/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 11</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Replace the outer needle cover on the needle. (<content styleCode="bold">See <linkHtml href="#IFU3_FigJ">Figure J</linkHtml>
                                    </content>)</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph ID="IFU3_FigJ">
                                 <content styleCode="bold">Figure J</content>
                                 <renderMultiMedia ID="id-1418853781" referencedObject="ID_66f1659e-9661-4f03-8705-e67810221200"/>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph ID="IFU3_Step12">
                     <content styleCode="bold">Step 12. Throwing away (disposing of) your GENOTROPIN MINIQUICK and needles</content>
                  </paragraph>
                  <paragraph>Put the used GENOTROPIN MINIQUICK and needles in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) the needles and syringes in the household trash.</paragraph>
                  <paragraph>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Made of a heavy-duty plastic,</item>
                     <item>
                        <caption>â¢</caption>Can be closed with a tight fitting, puncture-resistant lid, without sharps being able to come out,</item>
                     <item>
                        <caption>â¢</caption>Upright and stable during use,</item>
                     <item>
                        <caption>â¢</caption>Leak-resistant, and</item>
                     <item>
                        <caption>â¢</caption>Properly labeled to warn of hazardous waste inside the container.</item>
                  </list>
                  <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: <linkHtml href="https://www.fda.gov/medical-devices/consumer-products/safely-using-sharps-needles-and-syringes-home-work-and-travel">http://www.fda.gov/safesharpsdisposal</linkHtml>.</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> reuse the GENOTROPIN MINIQUICK or needles.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> throw away (dispose of) your used sharps disposal container in your household trash unless your community guidelines permit this.</item>
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="bold">Do not</content> recycle your used sharps disposal container.</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Important</content>: Always keep the sharps disposal container out of the reach of children.</paragraph>
                  <table width="90%">
                     <col width="50%"/>
                     <col width="50%"/>
                     <thead>
                        <tr>
                           <th align="left" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <content styleCode="bold">Questions and Answers</content>
                           </th>
                        </tr>
                        <tr>
                           <th align="left" styleCode="Rrule Lrule Botrule " valign="top">
                              <content styleCode="bold">Question</content>
                           </th>
                           <th align="left" styleCode="Rrule Botrule " valign="top">
                              <content styleCode="bold">Answer</content>
                           </th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <paragraph>Is it a problem if I see air bubbles in the syringe?</paragraph>
                           </td>
                           <td styleCode="Rrule Toprule Botrule " valign="top">
                              <paragraph>No. There is no need to remove the air bubbles from the GENOTROPIN MINIQUICK. The small amount of air in the syringe does not affect your injection.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>What should I do if I have problems turning the plunger rod (Step 6)?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The problem could be because the needle has been inserted at an angle onto the rubber stopper.<br/>Carefully replace the outer needle cover on the needle and unscrew counterclockwise (turn to the left) to remove the needle. Hold the GENOTROPIN MINIQUICK with the needle-end pointing up, and re-attach and screw the needle directly (not at an angle) on top of the device.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>What should I do if I have problems pushing the plunger when making the injection (Step 10)?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>The problem could be because the needle has been inserted at an angle onto the rubber stopper.<br/>Carefully replace the outer needle cover on the needle and unscrew counterclockwise (turn to the left) to remove the needle. Hold the GENOTROPIN MINIQUICK with the needle-end pointing up, and re-attach and screw the needle directly (not at an angle) on top of the device.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>What should I do if the needle is damaged or bent?</paragraph>
                           </td>
                           <td styleCode="Rrule Botrule " valign="top">
                              <paragraph>Throw away the needle and use a new needle with the GENOTROPIN MINIQUICK.<br/>
                                 <content styleCode="bold">See "<linkHtml href="#_Refthrowingaway">Disposing of (throwing away) your GENOTROPIN MINIQUICK and needles</linkHtml>".</content>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider right away.</paragraph>
                  <paragraph>Use this device only for the person for whom it was prescribed.</paragraph>
                  <paragraph>
                     <content styleCode="bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>Manufactured by:<br/>Pharmacia &amp; Upjohn Company LLC<br/>A subsidiary of Pfizer Inc.<br/>New York, NY 10001<br/>
                     <br/>U.S. License No. 1216<br/>
                     <renderMultiMedia ID="id278456482" referencedObject="BF1F1E9E-A08A-410A-BD0B-A25F11BA4CFF"/>
                  </paragraph>
                  <paragraph>LAB-0227-9.0<br/>Revised: August 2024</paragraph>
                  <renderMultiMedia ID="id73321441" referencedObject="ID_9c7bedad-c96a-47aa-b7f8-904719de6dcc"/>
               </text>
               <effectiveTime value="20240823"/>
               <component>
                  <observationMedia ID="F8424B89-4396-462D-9A72-9CA527A2324B">
                     <text>Figure A</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-78.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_58b41065-ee5c-4c55-8cec-e153c02468a0">
                     <text>Figure B</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-79.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="BAA6DFD8-C784-4428-9D47-568F8B7F8B28">
                     <text>Figure C</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-80.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_85418c8a-6212-4bb6-adc3-6b80b4c15206">
                     <text>Figure D</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-81.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_21300134-71e2-421f-959c-eda8442d7508">
                     <text>Figure E</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-82.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A9F933FB-0610-4639-AB40-7A97922A03C0">
                     <text>Figure F</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-83.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A8B67C82-DE80-4C06-ADC4-BA184AE6EBBE">
                     <text>Figure G</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-84.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="B699686F-FE4D-40F6-85EF-E42FDAC7CFEC">
                     <text>Figure H</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-85.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_30914782-9e36-4e29-87ee-2d279ea8fd98">
                     <text>Figure I</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-86.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_66f1659e-9661-4f03-8705-e67810221200">
                     <text>Figure J</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-87.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="BF1F1E9E-A08A-410A-BD0B-A25F11BA4CFF">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-88.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9c7bedad-c96a-47aa-b7f8-904719de6dcc">
                     <text>Logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-89.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_1693ccca-f8dc-4f53-b207-2aba866261b0">
               <id root="46db7398-c7bd-40cc-a02f-57db5697d159"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 5 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Two-chamber cartridge<br/>For s.c. injection. 5 mg/mL<br/>Refrigerate. Protect from light.<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>5 mg</paragraph>
                  <paragraph>NDC 0013-2626-81</paragraph>
                  <paragraph>LOT/EXP<br/>PAA185891</paragraph>
                  <renderMultiMedia ID="id5681" referencedObject="MM94"/>
               </text>
               <effectiveTime value="20230426"/>
               <component>
                  <observationMedia ID="MM94">
                     <text>PRINCIPAL DISPLAY PANEL - 5 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-94.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6017a3f4-8f09-423c-824b-cd3747f116eb">
               <id root="e5d0bad3-6d79-4d58-afd9-eb644cb40524"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 5 mg Kit Carton</title>
               <text>
                  <paragraph>Pfizer<br/>Genotropin<sup>Â®</sup>
                     <br/>5 mg</paragraph>
                  <paragraph>(somatropin) for injection<br/>NDC 0013-2626-81</paragraph>
                  <paragraph>For subcutaneous injection<br/>Rx only<br/>1 Two-Chamber Cartridge</paragraph>
                  <paragraph>PAA185820</paragraph>
                  <paragraph>OPEN HERE</paragraph>
                  <renderMultiMedia ID="id5706" referencedObject="MM95"/>
               </text>
               <effectiveTime value="20230426"/>
               <component>
                  <observationMedia ID="MM95">
                     <text>PRINCIPAL DISPLAY PANEL - 5 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-95.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_08fb8d08-eb2b-4855-9e55-93edf8ad0e5a">
               <id root="069e02c1-3ef8-4cf7-a094-f114d2117cb7"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 12 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Two-chamber cartridge<br/>For s.c. injection. 12 mg/mL<br/>Refrigerate. Protect from light.<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>12 mg</paragraph>
                  <paragraph>NDC 0013-2646-81</paragraph>
                  <paragraph>LOT/EXP<br/>PAA185895</paragraph>
                  <renderMultiMedia ID="id5732" referencedObject="MM96"/>
               </text>
               <effectiveTime value="20230426"/>
               <component>
                  <observationMedia ID="MM96">
                     <text>PRINCIPAL DISPLAY PANEL - 12 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-96.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_111b0211-5eb2-4553-aa8e-867f58a4e7d0">
               <id root="8e35a9cd-7f81-4fbf-96fb-690c7ea356d1"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 12 mg Kit Carton</title>
               <text>
                  <paragraph>Pfizer<br/>Genotropin<sup>Â®</sup>
                     <br/>12 mg</paragraph>
                  <paragraph>(somatropin) for injection<br/>NDC 0013-2646-81</paragraph>
                  <paragraph>For subcutaneous injection<br/>Rx only<br/>1 Two-Chamber Cartridge</paragraph>
                  <paragraph>PAA185893</paragraph>
                  <paragraph>OPEN HERE</paragraph>
                  <renderMultiMedia ID="id5757" referencedObject="MM97"/>
               </text>
               <effectiveTime value="20230426"/>
               <component>
                  <observationMedia ID="MM97">
                     <text>PRINCIPAL DISPLAY PANEL - 12 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-97.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_0a1143c1-312d-40a7-a1d0-9172a09cc323">
               <id root="84162e0c-1fd3-4929-9071-82eb41892bc3"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.2 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>0.2 mg</paragraph>
                  <paragraph>NDC 0013-2649-01</paragraph>
                  <paragraph>PAA142719</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id5784" referencedObject="MM98"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM98">
                     <text>Principal Display Panel - 0.2 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-98.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_62dd62e6-b028-48b7-8081-bb13a5f80ee2">
               <id root="9b11edf9-7638-4198-b5e7-c22a55499ee7"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.2 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2649-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>0.2 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id5809" referencedObject="MM99"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM99">
                     <text>Principal Display Panel - 0.2 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-99.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_88b466f3-a8e1-433a-b93f-42c8dbd88a1d">
               <id root="f728e4bd-4fbd-41f7-9dca-284c696be560"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.4 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>0.4 mg</paragraph>
                  <paragraph>NDC 0013-2650-01</paragraph>
                  <paragraph>PAA142720</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id5836" referencedObject="MM100"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM100">
                     <text>Principal Display Panel - 0.4 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-100.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6cc76977-f834-47cc-8011-0892e8d6d5d3">
               <id root="f4043dd7-0e9d-4bb4-bc22-aab23bb97d88"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.4 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2650-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>0.4 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id5861" referencedObject="MM101"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM101">
                     <text>Principal Display Panel - 0.4 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-101.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ecd2bce2-f088-40aa-ad54-10c283a304ad">
               <id root="d2c31214-4749-4a80-8a38-d520978077f8"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.6 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>0.6 mg</paragraph>
                  <paragraph>NDC 0013-2651-01</paragraph>
                  <paragraph>PAA142731</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id5888" referencedObject="MM102"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM102">
                     <text>Principal Display Panel - 0.6 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-102.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_84cf8ae8-8bc1-4e14-b407-455be047ffa6">
               <id root="60a21b70-468c-4120-adb7-5c89f78ca3b2"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.6 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2651-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>0.6 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id5913" referencedObject="MM103"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM103">
                     <text>Principal Display Panel - 0.6 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-103.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_61389cc7-07d1-4c4d-9064-9dbbd6db7266">
               <id root="185767b5-ea9a-488e-92ef-da8cb8322fcb"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.8 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>0.8 mg</paragraph>
                  <paragraph>NDC 0013-2652-01</paragraph>
                  <paragraph>PAA142732</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id5940" referencedObject="MM104"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM104">
                     <text>Principal Display Panel - 0.8 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-104.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ea6aed1f-86e5-46fb-bc30-3a7ebab9f54c">
               <id root="f75d4ecf-ee8a-4287-9ca1-66520108e5b2"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 0.8 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2652-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>0.8 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id5965" referencedObject="MM105"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM105">
                     <text>Principal Display Panel - 0.8 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-105.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_328065dc-3398-42ef-a662-681aeccf1ad6">
               <id root="39c34802-383b-4f48-a005-bc8bc2205a44"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>1 mg</paragraph>
                  <paragraph>NDC 0013-2653-01</paragraph>
                  <paragraph>PAA142733</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id5992" referencedObject="MM106"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM106">
                     <text>Principal Display Panel - 1 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-106.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_20e2ba26-5760-4c1c-b0c3-efbc4c0e1607">
               <id root="ebcaa8cf-d8ab-4623-8ba3-f9d58e83fd89"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2653-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>1 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6017" referencedObject="MM107"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM107">
                     <text>Principal Display Panel - 1 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-107.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_7d3bdc1f-ac00-4ad2-a20c-3ea907772520">
               <id root="f14efd76-96e7-4ee8-9dda-8614536ec412"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.2 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>1.2 mg</paragraph>
                  <paragraph>NDC 0013-2654-01</paragraph>
                  <paragraph>PAA142734</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id6044" referencedObject="MM108"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM108">
                     <text>Principal Display Panel - 1.2 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-108.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_e0394378-8ee4-4f35-b5e5-d8457175077f">
               <id root="ecb8505d-8193-44c4-b4f4-415727d95aff"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.2 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2654-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>1.2 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6069" referencedObject="MM109"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM109">
                     <text>Principal Display Panel - 1.2 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-109.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_37514104-f71a-463d-80af-4807a8d3058c">
               <id root="5f78132e-45a0-4755-81b0-5f5a80607c55"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.4 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>1.4 mg</paragraph>
                  <paragraph>NDC 0013-2655-01</paragraph>
                  <paragraph>PAA142735</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id6096" referencedObject="MM110"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM110">
                     <text>Principal Display Panel - 1.4 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-110.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5d87e6c0-aa88-4b0e-bdc6-746338e25a14">
               <id root="66ac7ac7-6bbd-4340-acfe-e8ced3478490"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.4 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2655-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>1.4 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6121" referencedObject="MM111"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM111">
                     <text>Principal Display Panel - 1.4 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-111.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_1b4b91f3-81e5-4815-abb3-e91aea43e725">
               <id root="cab55ed1-92fb-4365-9761-00d3e0e0b2b8"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.6 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>1.6 mg</paragraph>
                  <paragraph>NDC 0013-2656-01</paragraph>
                  <paragraph>PAA142736</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id6148" referencedObject="MM112"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM112">
                     <text>Principal Display Panel - 1.6 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-112.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_e14ea993-4d34-4f68-bcb1-9e0053bcd820">
               <id root="6a2646e0-596c-4673-9550-902ba6e673c5"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.6 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2656-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>1.6 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6173" referencedObject="MM113"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM113">
                     <text>Principal Display Panel - 1.6 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-113.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_173a53d4-d8ae-46b6-bf6b-82d3502188cc">
               <id root="90acf016-82d8-4b4c-8094-7eafdd1f7621"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.8 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>1.8 mg</paragraph>
                  <paragraph>NDC 0013-2657-01</paragraph>
                  <paragraph>PAA142737</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id6200" referencedObject="MM114"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM114">
                     <text>Principal Display Panel - 1.8 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-114.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2258fdf5-cfc1-4eb6-83cf-b74c914cf936">
               <id root="ce8ede8c-a0bb-4701-9217-589d259a3b05"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1.8 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2657-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>1.8 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6225" referencedObject="MM115"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM115">
                     <text>Principal Display Panel - 1.8 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-115.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_fc74578a-c72a-431a-a221-8865b53186da">
               <id root="b6e7734c-3068-477d-a72d-c04d4eaf98ac"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 2 mg Cartridge Label</title>
               <text>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection<br/>Genotropin MiniQuick<sup>Â®</sup>
                     <br/>Growth Hormone Delivery Device<br/>Pharmacia &amp; Upjohn Co<br/>Div of Pfizer Inc, NY, NY 10017</paragraph>
                  <paragraph>2 mg</paragraph>
                  <paragraph>NDC 0013-2658-01</paragraph>
                  <paragraph>PAA142738</paragraph>
                  <paragraph>LOT<br/>EXP</paragraph>
                  <renderMultiMedia ID="id6252" referencedObject="MM116"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM116">
                     <text>Principal Display Panel - 2 mg Cartridge Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-116.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_13de8025-0827-46fb-85e9-91ae1aa66ae4">
               <id root="4571d9fe-38f7-4917-9f4e-d1e10a25beee"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 2 mg Kit Carton</title>
               <text>
                  <paragraph>NDC 0013-2658-02</paragraph>
                  <paragraph>Pfizer</paragraph>
                  <paragraph>Genotropin<sup>Â®</sup>
                     <br/>(somatropin) for injection</paragraph>
                  <paragraph>2 mg Genotropin MiniQuick<sup>Â®</sup>
                  </paragraph>
                  <paragraph>For single subcutaneous injection only<br/>Growth Hormone Delivery Device</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>7 Pack</paragraph>
                  <renderMultiMedia ID="id6277" referencedObject="MM117"/>
               </text>
               <effectiveTime value="20190401"/>
               <component>
                  <observationMedia ID="MM117">
                     <text>Principal Display Panel - 2 mg Kit Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="genotropin-117.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>